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THE FUNCTIONAL SIGNIFICANCE OF THE EXCITATORY EFFECTS OF GABA IN THE
SUPRACHIASMATIC NUCLEUS

by

JOHN KNOX MCNEILL IV

Under the Direction of H. Elliott Albers, PhD

ABSTRACT
Circadian rhythms are found in most all organisms and represent an evolutionary
adaptation to environmental cycles resulting from the earth’s rotation. One of the most important
functions of a circadian clock is to ensure that biological functions occur at appropriate times of
the day. The suprachiasmatic nucleus (SCN) is a circadian clock that controls a host of rhythms
such as sleep/wake cycles, hormone release, blood pressure, liver function, and neuronal activity.
The SCN synchronizes circadian rhythms with the day-night cycle through a process known as
entrainment. Entrainment is the process by which light resets the clock to match the 24-hr daynight cycle. γ-aminobutyric acid (GABA) is found in nearly all SCN neurons and contributes to
the entrainment of circadian rhythms to the day-night cycle and plays a critical role in the ability
of non-photic cues to reset the clock. GABA is the primary inhibitory neurotransmitter in the

brain, but a growing body of literature indicates that GABA also acts as an excitatory
neurotransmitter in many brain regions. These excitatory responses to GABA are dependent on
chloride ion gradients maintained by chloride cotransporters (CCCs), and especially the chloride
influx Na+/K+/Cl- cotransporter (NKCC1). Researchers have observed these excitatory responses
to GABA in the SCN for over 20 years, yet surprisingly little work has addressed the functional
role of these responses in entrainment or determined if the changes in excitatory GABA
signaling throughout the day are due to fluctuations in NKCC1 expression. This dissertation
seeks to address the lack of knowledge regarding these excitatory responses to GABA by: (1)
characterizing the functional effects of excitatory GABA responses in the resetting of the clock
by light; (2) investigating the role of excitatory responses in the resetting effects of non-photic
stimuli; (3) determining if light duration alters NKCC1 protein; and (4) determining if the levels
of NKCC1 occur in a circadian and/or daily rhythm in the SCN. These experiments together
provide evidence of a functional role for GABA excitation in entrainment of the SCN and also
contribute to our understanding of CNS GABA signaling mechanisms, in general.
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1
1.1

INTRODUCTION

A brief history of chronobiology
The study of rhythms and cycles in biology (chronobiology) has been of interest to humans

and recognized as important for other organisms for thousands of years. Theophrastus of Eresos
(371-287 BCE), citing the trierarch to Alexander, Androsthenes of Thasos, wrote of a tree that
closed its leaves at night and opened its leaves at sunrise, that the natives said went to sleep. Fast
forward 2,000 years and botanists were again on the cutting edge of the field of chronobiology.
Jean-Jacque d’Ortous de Mairan (1678-1771) noted that Mimosa pudica (pudica, Latin for
bashful or shrinking) “…perceives the sun without seeing it.” Augustin Pyramus de Candolle
(1778-1841) noted that this same sleeping plant displayed rhythmicity that persisted in constant
light, but with a period shorter than 24 hours. Curt P. Richter (1894-1989), in 1922, observed
endogenous rest and activity rhythms in animals. Shortly thereafter, a young graduate student in
Berlin, named Erwin Bünning, began publishing findings about the endogenous rhythms in
plants and became one of the fathers of the field, ultimately suggesting that light is the primary
zeitgeber (time-giver) for synchronization of biological rhythms and that light leads to responses
during certain phases of the circadian cycle (The Bünning Hypothesis). Colin Pittendrigh, by
studying the eclosion rhythm of fruit flies and Jürgen Aschoff studying the rhythms of birds,
mammals, and humans, added their names to complete a trinity of founders of circadian biology.
Pittendrigh and Aschoff reached opposing conclusions about these rhythms, which ultimately
became their non-parametric and parametric theories of entrainment, respectively (discussed
below). A few years later, early neurogeneticists, Ron Konopka and Seymour Benzer, identified
a gene in fruit flies using an EMS mutagenesis screen, naming it Period. This early work laid the
groundwork for a Nobel prize recently awarded to Jeff Hall, Michael Rosbash, and Michael
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Young for “discovering of molecular mechanisms controlling the circadian rhythm”, what
circadian biologists ultimately referred to as the transcription/translation feedback loop (TTFL).
In the early 1970s, the combination of the discovery of a monosynaptic connection from the
retina to a small nucleus in the anterior hypothalamus with lesion studies to this nucleus that
eliminated the drinking and corticosterone rhythms, led to the discovery of the suprachiasmatic
nucleus (SCN) as the site of a master circadian pacemaker (Moore and Eichler, 1972; Moore
and Lenn, 1972; Stephan and Zucker, 1972).
The SCN controls a host of physiological and behavioral circadian rhythms. Ever since
its discovery, this pacemaker has been extensively studied, becoming one of the most well
described nuclei in the brain with well-known inputs and behavioral outputs. Study of the SCN
has proven invaluable in its ability to advance chronobiology, specifically circadian rhythms, but
has also advanced the understanding of network activity within the whole body.
1.2

The molecular clock
It is well established that individual SCN neurons are capable of generating circadian

rhythmicity through a set of core and accessory TTFLs (For review (Hastings et al., 2014)). SCN
“clock cells” contain a TTFL with positive elements that drive transcription and negative
elements that repress transcription. The positive elements of the core molecular clock include the
transcription factors BMAL1 and CLOCK and the negative elements, the PERIOD proteins
(PER1, PER2, and PER3) and CRYPTOCHROME proteins (CRY1 and CRY2). Briefly, the core
clock mechanism of the TTFL, from an arbitrary beginning point in the cycle, begins with
CLOCK and BMAL1 dimerizing and activating Per and Cry genes which lead to an increase in
PER and CRY proteins. PER and CRY proteins dimerize, translocate into the nucleus, and
inhibit their own transcription by repressing CLOCK-BMAL1 activity as transcription factors of
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Per and Cry. The decreasing levels of Per and Cry lead to decreased PER/CRY dimers and,
ultimately, to the dis-inhibition of CLOCK-BMAL1 dimers, resulting in the reactivation of Per
and Cry transcription. The TTFL found in individual circadian clock cells couples with other
neurons in the nucleus to form a network level circadian pacemaker within the SCN. It is now
recognized that many of these clock elements maintain rhythmic activity in cells throughout the
body.
1.3

Projections to the SCN
Several major afferent pathways project to the SCN, including a direct projection from

the retina (the retinohypothalamic tract (RHT)), a direct projection from the intergeniculate
leaflet of the thalamus called the geniculo-hypothalamic tract (GHT), and a direct serotonergic
projection from the median raphe nucleus (Hendrickson et al., 1972; Moore and Lenn, 1972;
Ribak and Peters, 1975; Card and Moore, 1982; Pickard, 1982; Pickard, 1985; Harrington et
al., 1987; Moore and Card, 1994; Meyer-Bernstein and Morin, 1996; Morin, 1999)(Figure
1.1). Each of these projections can influence the phase of the circadian pacemaker. In addition to
these major projections, however, there are a large number of less prominent connections. In
fact, it has been estimated that around 85 distinct brain regions send projections to the SCN
(Morin, 2013).
The RHT is often recognized as the most important input for communicating photic
information to the SCN as its destruction eliminates the ability of an animal to entrain to the
light-dark (LD) cycle (Johnson et al., 1988a). There is considerable evidence that glutamate
serves as the primary neurotransmitter released from the RHT onto, predominantly, the ventral
SCN. For example, administration of glutamate agonists (e.g., NMDA) into the SCN mimics the
phase shifting effects of light, and glutamate antagonists block the phase shifting effects of light
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(Colwell et al., 1991; Colwell and Menaker, 1992; Mintz and Albers, 1997; Mintz et al., 1999;
Novak and Albers, 2002; Gamble et al., 2003). Nevertheless, other neurochemical signals
released from RHT terminals may contribute to entrainment to light (Ebling, 1996; Golombek
and Rosenstein, 2010).
1.4

Neuroanatomical subdivisions of the SCN
The bilateral SCN in mammals contains a population of around 20,000 neurons as well as

glial cells (Van den Pol, 1980). The SCN is often divided into two regions based on
neuroanatomical and functional criteria and some have described a third division (Morin, 2007).
The regions are often referred to as the ventral/ ventrolateral and/or ‘core’ SCN (vSCN) and the
dorsal/dorsomedial and/or shell SCN (dSCN)(Figure 1.1) (Hastings and Herzog, 2004; Antle et
al., 2005b; Morin, 2007; Yan et al., 2007; Antle et al., 2009; Evans, 2016; Evans and Gorman,
2016).
1.4.1

vSCN
The vSCN receive direct input from the retina via the retinohypothalamic tract (RHT)

(Morin, 2013)(Figure 1.1). The vSCN contain vasoactive intestinal peptide (VIP) and peptide
histidine isoleucine (PHI) as well as gastrin releasing peptide (GRP)-producing neurons (van den
Pol and Tsujimoto, 1985; Stopa et al., 1988). In Syrian hamsters, a calbindin rich area is also
found in this region (Silver et al., 1996). VIP and PHI derive from a common precursor and,
thus, are often co-expressed in vSCN neurons (Nishizawa et al., 1985; Romijn et al., 1998). A
sub-group of vSCN VIP neurons also produce GRP (Albers et al., 1991; Romijn et al., 1998).
Inputs from the RHT directly synapse on some VIP and GRP neurons (Ibata et al., 1989; Aioun
et al., 1998). Light input can regulate the levels of these neuropeptides within the vSCN (Albers
et al., 1987; Albers et al., 1990; Zoeller et al., 1992; Shinohara et al., 1993). Light decreases
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VIP mRNA and protein and increases GRP mRNA and protein in rodents housed in LD cycles.
vSCN neurons display increased levels of Per1 and Per2 mRNA and protein in response to
phase shifting light pulses (Yan et al., 1999; Hamada et al., 2001; Karatsoreos et al., 2004;
Francl et al., 2010a;

Francl et al., 2010b). In fact, light input in the night induces Per1

expression in the vSCN, even at phases at which light does not produce behavioral phase shifts
(Yan and Silver, 2002).
1.4.2

dSCN
In contrast, arginine-vasopressin (AVP) is highly expressed in the dSCN (Vandesande et

al., 1975; Card and Moore, 1984; van den Pol and Tsujimoto, 1985). The RHT projects to both
the vSCN and dSCN, however, these projections are sparser in the dSCN (Moore and Card,
1985; Muscat et al., 2003; Hattar et al., 2006; Morin and Allen, 2006; Morin et al., 2006). The
dSCN has a large number of neurons that exhibit endogenous single cell rhythms in Per1 and
Per2 mRNA, explaining why some researchers have referred to these dSCN neurons as ‘clock
cells’ (Guido et al., 1999; Yan et al., 1999; Hamada et al., 2001). Furthermore, the dSCN lags
behind the vSCN, such that, upon light receipt from the RHT, increases and phase shifts in Per
gene mRNA and phase shifts in firing rate rhythms occur well after these processes begin in the
vSCN (Silver et al., 1996; Albrecht et al., 1997; Yan et al., 1999; Yamamoto et al., 2001; Lily
and Rae, 2002; Yan and Silver, 2002; Hamada et al., 2004a; Albus et al., 2005) (Yan and
Okamura, 2002; Yan and Silver, 2002; Nagano et al., 2003; Yan and Silver, 2004; Albus et al.,
2005). Despite the debate surrounding these divisions over many years of study, the
ventral/dorsal description has proven useful for describing the way in which the pacemaker
entrains to photic input.

6

1.5

Entrainment
Entrainment is originally from the French, entrainer, ‘to carry along’. Thus, entrainment is

to board a train of stimuli and have the rhythm pulled along in time (Johnson et al., 2003). This is
often confused with synchronization; however, entrainment does not require similar rhythm
waveforms, as does synchrony. Circadian clocks (circa “around” and dies “day”) display a
period that is not exactly 24 hours and each day these clocks are adjusted to the ambient light
cycle such that internal physiological rhythms occur at appropriate times of the day. Entrainment
of the SCN to light input requires a series of neurochemical events that ultimately transduce light
into a signal that phase shifts the firing, genetic rhythms, and physiology and behavior of the
organism.
1.5.1

Entrainment of the vSCN and dSCN
Many researchers offer hypotheses on the mechanisms the SCN uses to mediate

entrainment to light (Albers et al., 1992; Hastings and Herzog, 2004; Antle et al., 2005a; Yan
et al., 2007). A parsimonious explanation as to how the nucleus shifts firing, gene expression,
and ultimately whole body physiology is that “non-rhythmic” cells in the vSCN receive light
input via the RHT and respond by adjusting to the appropriate phase. Next, via dense projections,
vSCN neurons communicate the new phase information to rhythmic dSCN ‘clock cells’ (Leak et
al., 1999). Thus, a phase shift occurs via a combination of amino acid and neuropeptide
neurotransmitter communication from the vSCN to the dSCN that brings these two sub-nuclei
back into internal synchrony with a rhythm corresponding to the adjusted schedule as determined
by the external stimulus. It is important to note that endogenous circadian oscillations are not
entirely restricted to the dSCN and that sub-populations within these regions may even serve
other purposes beyond the maintenance and adjustment of circadian rhythms (Albus et al., 2005;
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Evans et al., 2013; Myung et al., 2015b). Indeed, work utilizing cultured SCN neurons shows
both vSCN VIP+ and dSCN AVP+ neurons can exhibit endogenous rhythmicity, and that these
neuropeptidergic cells are a small percentage of the total cells displaying circadian rhythmicity
(Webb et al., 2009). Thus, it is obvious that the vSCN/dSCN convention is oversimplified.
However, the concept of rhythmic and non-rhythmic light-responsive elements has proven useful
and provides a strong explanation of the functional divisions within the SCN. While the presence
of both intrinsically rhythmic and light-responsive elements is a common feature across species,
the neuroanatomical distribution of these elements and their neurochemical phenotype differ
between species (Yan and Okamura, 2002; Yan and Silver, 2002; Lee et al., 2003).
1.6

Intra-SCN neuronal communication
There is certainly the need for more research around how SCN neurons communicate to

light shifting information and reach a consensus rhythm; thus it is important to offer a brief
description of some of the ways in which SCN neurons communicate (for reviews:(van den Pol
and Dudek, 1993; Michel and Colwell, 2001)). SCN neurons are relatively small (around 10
uM) and are closely apposed. Synaptic communication within the SCN is necessary for the
entrainment of the pacemaker with the LD cycle and, importantly, most of these synapses are
GABAergic (Schwartz et al., 1987; Schwartz, 1991; Strecker et al., 1997). However, other lines
of evidence suggest that synaptic activity only plays a limited role in the ability of the SCN to
keep time (Schwartz et al., 1987; Schwartz, 1991; Bouskila and Dudek, 1993; Honma et al.,
2000; Shirakawa et al., 2000; Yamaguchi et al., 2003). In addition to synaptic communication,
non-synaptic release of neurochemical signals may also be critical in intra-SCN neuronal
signaling. Signaling between neurons at sites outside of the classic active zone of the synapse is
increasingly recognized as important for neuronal communication (Leng and Ludwig, 2008;

8

Stoop, 2012; Trueta and De-Miguel, 2012). There is evidence for inter-dendritic and intersomatic appositions in the SCN and these appositions may mediate non-synaptic communication
(Van den Pol, 1980; Castel et al., 1996; Guldner and Wolff, 1996). As mentioned above, SCN
neurons are tightly packed, making it more likely for even small amounts of extrasynaptic
GABA release to raise extracellular levels of GABA and other key neurotransmitters (Van den
Pol, 1980). Gap junctions are also present between SCN neurons, thus SCN neurons may also
communicate directly through electrotonic coupling (Jiang et al., 1997b;
Shirakawa et al., 2000; Long et al., 2005; Rash et al., 2007).

Figure 1-1: Core/shell subregions of SCN

Colwell, 2000;
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Schematic diagram of the ventral core/dorsal shell conceptualization of the organization
of the suprachiasmatic nucleus illustrating the anatomical and functional heterogeneity of the
nucleus. Major afferent pathways including the retinohypothalamic tract (RHT),
geniculohypothalamic tract (GHT), and a projection from the raphe nucleus (Raphe) terminate
primarily in the ventral core, although RHT terminals can also be found in the dorsal shell.
Neurons in the ventral core contain GABA and a variety of neuropeptides including vasoactive
intestinal peptide (VIP) and gastrin releasing peptide (GRP), all of which are frequently
colocalized in the same neuron. Some neurons in the ventral core display endogenous
rhythmicity (wave) while others do not (dash). In the dorsal shell, more neurons display
endogenous rhythmicity. Neurons in the dorsal shell contain GABA and neuropeptides including
arginine-vasopressin (AVP), all of which are frequently colocalized in the same neuron. Neurons
in the dorsal shell and ventral core can communicate via GABA and other neurochemical signals
(Albers et al., 2017).
1.7

γ-aminobutyric acid (GABA) in the SCN
GABA-receptor mediated inhibition is a key regulator of the firing patterns in both

simple and complex networks of the nervous system. Though a lot has been learned, GABA
function often presents challenges to study due to its ubiquity in different circuits and the
complex features of GABA signaling. The SCN is a network of GABAergic cells with GABA
synthesis, release, and receptor proteins expressed in most SCN neurons (Decavel and Van den
Pol, 1990; Castel and Morris, 2000b; Moore et al., 2002b)(Figure 1.2). Estimates of the
percentage of SCN neurons producing GABA range from over 50% to nearly all neurons in the
nucleus (van den Pol and Tsujimoto, 1985; Okamura et al., 1989; Francois-Bellan et al., 1990;
Moore and Speh, 1993; Buijs et al., 1995; van den Pol et al., 1996; Tanaka et al., 1997; Castel
and Morris, 2000b). As in other nuclei, GABA in the SCN is in most local circuit neurons and
found in GABAergic terminals from projections originating just outside the nucleus and from
more distant, non-hypothalamic sites (e.g., IGL) (van den Pol and Tsujimoto, 1985; van den Pol
and Gorcs, 1986; Kim and Dudek, 1992; Buijs et al., 1994; Jiang et al., 1997a; Strecker et al.,
1997; Morin and Blanchard, 2001).
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GABAA receptor (GABAAR) signaling is crucial for synchronization of SCN sub nuclei
and regulates phase shifting of SCN neurons in vitro and in vivo (Liu and Reppert, 2000; Albus
et al., 2005; Hummer et al., 2015; Albers et al., 2017). For instance, we recently showed that
the sustained activation (≥ 4 hrs.) of SCN GABAARs in the early subjective night mimics the
phase delaying effects of light and that the sustained administration of the GABAAR antagonist,
bicuculline, blocks the phase delaying effects of light (Hummer et al., 2015). These findings
suggest that a sustained GABA signal following a phase adjusting light pulse is an important
neurochemical signal for SCN entrainment to light. Furthermore, GABAAR signaling regulates
light-induced changes in core molecular clock genes (Period 1 and 2), necessary for the
maintenance of circadian rhythms (Ehlen et al., 2006; Novak et al., 2006; Ehlen et al., 2008).
The long-term goal of this work is to better understand the role SCN GABA signaling, and
specifically excitatory GABA signaling, plays in the entrainment of circadian rhythms.
Importantly, neurons often release more than just one neurochemical signal and reports
indicate that GABA can be released with other low molecular weight amino acid
neurotransmitters, such as glycine and glutamate (Tritsch et al., 2016)(Figure 1.3). In addition,
GABA can also be released with neuropeptides. Amino acid neurotransmitters like GABA are
normally packaged in small synaptic vesicles (SSV) in pre-synaptic regions, whereas
neuropeptides are found in large dense-core vesicles (LDCV) in pre-synaptic areas but also at
sites distant from the synaptic density of the axon terminal. These LDCVs are found in
GABAergic neurons of the SCN, suggesting the presence of both key SCN neuropeptides and
GABA within the same neuron (Decavel and Van den Pol, 1990). This co-localization of amino
acid neurotransmitters and neuropeptides is now thought to be a common feature of the nervous
system (for reviews see (van den Pol, 2012; Albers, 2015).
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GABA is primarily packaged in SSVs in the SCN; however, GABA has also been
observed in LDCVs (van den Pol and Gorcs, 1986; Castel and Morris, 2000b). It is possible that
these GABAergic LDCVs are allowing GABA release in non-synaptic regions powered by local
Ca2+ influx from voltage –gated channels in close proximity to the LDCVs, or plasma membrane
voltage-independent release of Ca2+ from intracellular stores (Figure 1.3). This type of LDCV
exocytosis, (i.e., from release of intracellular Ca2+), has been demonstrated in other hypothalamic
nuclei and may occur without substantial changes in electrical activity, as voltage-gated Ca2+
influx is not required. After exocytosis, this neurotransmitter release outside of the synaptic cleft,
termed volume transmission, is capable of producing diffuse effects as far as 5 mm from the site
of release (Engelmann et al., 2000; Fuxe et al., 2010). Volume transmission has mostly been
characterized by studying the non-synaptic release of neuropeptides, however, volume
transmission may also be a mechanism that regulates low molecular weight neurotransmitter
(e.g., GABA) release from neurons and/or astrocytes (Rossi et al., 2003; Trueta and De-Miguel,
2012; Rozsa et al., 2017).
As described above, GABAergic neurons are ubiquitous in the SCN and it appears
GABA is more often co-localized with VIP/PHI neurons of the retinorecipient nucleus than with
AVP-expressing neurons of the dSCN (Francois-Bellan et al., 1990; Buijs et al., 1995; Castel
and Morris, 2000b). Dual-labeled electron micrographs suggest that GABA may be found in up
to 70% of VIP-positive terminal boutons and only 35% of AVP-positive boutons (Castel and
Morris, 2000b). In addition, it is also possible that more than one neuropeptide is released from
these same terminals. For example, some GABA and VIP/PHI containing neurons may also
release GRP (Okamura et al., 1986; Albers et al., 1991; Romijn et al., 1997). This high
percentage of co-localization in vSCN neurons added to the presence of dense, direct projections
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from neurons in the vSCN to the dSCN suggest that GABA may play a key role in synaptic
communication between retinorecipient vSCN neurons and more endogenously rhythmic
neurons of the dSCN (Romijn et al., 1997; Leak et al., 1999).
Another source of SCN GABA is from the terminals of the GHT and the serotonergic
projection from the raphe. The GHT contains both GABA and neuropeptide Y (NPY)-positive
neurons that primarily project to the ventrally located retinorecipient SCN (Moore and Card,
1994). Furthermore, these GABA and NPY projections often converge on the same postsynaptic
neurons of the vSCN and mediate functionally relevant GABA-NPY interactions. In the same
manner, there is also convergence of GABA and serotonin-containing terminals on the same
postsynaptic neurons of the SCN (Bosler, 1989; Francois-Bellan and Bosler, 1992). A large
number of the 5-hydroxytryptophan (5-HT) terminals are also within the retinorecipient vSCN.
These serotonergic terminals often inhibit presynaptic retinal input in this region via activation of
5-HT1b receptors, however, most of the 5-HT1b receptors are not found on the terminals of the
RHT (Pickard et al., 1996; Manrique et al., 1999). Instead, many of the 5-HT1b receptors are on
GABA terminals and their activation leads to an inhibition of GABA release (Bramley et al.,
2005).
In summary, GABA is in local circuit SCN neurons, terminals from projection neurons
originating from other nuclei, as well as in projections exiting the nucleus. GABA is a critical
neurotransmitter (NT) with roles in both well-studied subdivisions of the SCN and can exert its
effects via multiple types of neurochemical signaling. As with other amino acid NTs, GABA is
most often found packaged in SSVs in pre-synaptic regions, although GABA can be found in
LDCVs. Focal increase in Ca2+ from low frequency stimulation at the pre-synaptic membrane
can also lead to GABA release from SCN neurons, whereas high frequency stimulation most
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likely results in the release of neuropeptides along with GABA (Figure 1.3). Volume
transmission release of GABA can produce a very different type of GABA signaling that may be
involved in the coupling of circadian network neurons and/or serve as an output signal driving
the rhythmicity of other systems within the brain. The functional significance of the co-release of
GABA and neuropeptides in the SCN deserves further attention, as the dynamic interactions of
these signals may prove critical to our understanding of GABA function in timekeeping. Of
course, for GABA to regulate the SCN it must exert its effects through a receptor. Thus, a short
description of GABA receptors is in order.

Figure 1-2: Factors regulating GABA receptor signaling
Glutamic acid decarboxylase (GAD) catalyzes glutamic acid (GLU) into GABA in
presynaptic neurons (light red). There are two isoforms of GAD. GAD67 synthesizes GABA for
tonic release, while GAD65 synthesizes GABA for phasic release. GABA vesicular transporters
(VGATs) are responsible for the transport of GABA into synaptic vesicles (yellow). GABA
(white circles) can be found both in small synaptic vesicles (SSVs) and in large dense corevesicles (LDCVs). The exocytosis of SSVs and LDCVs occurs in response to increases in
intracellular calcium (Ca2+) resulting in the release of GABA into the extracellular space.
Increases in intracellular Ca2+can result from the influx of Ca2+through voltage-gated ion
channels as the result of an action potential or by the release of intracellular stores of Ca2+ from
the endoplasmic reticulum (ER) that do not require changes in electrical activity. GABAAPHASIC (purple), GABAA-TONIC (dark red) and GABAB (blue) receptors are found on both
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presynaptic terminals and postsynaptic sites. GABAA-PHASIC receptors are frequently found in
synaptic regions while GABAA-TONIC receptors are frequently found in extra-synaptic regions.
GABAB receptors can be found in both synaptic and extra-synaptic regions. GABA transporters
in the membrane (GATs) remove GABA from the extracellular space by a rapid reuptake of
GABA but can also release GABA. In the SCN, GAT1 and GAT3 (Green) are found on
astrocytic processes in extra-synaptic regions (Albers et al., 2017).

Figure 1-3: Co-release of peptides and other NTs
Hypothetical illustration of how different patterns of synaptic release of amino acid
neurotransmitters (NT) and colocalized neuropeptides (NP) could result from differences in
neuronal firing and neuropeptide biosynthesis. Each panel is an example of differences that
might occur in NT and NP release at a specific phase of the circadian cycle. (A) Moderate
neuronal firing (l l l l l l) produces moderate levels of calcium influx through voltage-gated ion
channels resulting in exocytosis of small synaptic vesicles (SSV; purple circles) and release of
NT. (B) High levels of neuronal firing (lllllllllll) produce high levels of calcium influx through
voltage-gated ion channels resulting in exocytosis of both SSVs and large dense-core vesicles
(LDCV; blue circles) resulting in release of NT and NP. (C) Two different neuropeptides are
packaged in LDCVs (red and blue) in a ratio of 1:1. High levels of neuronal firing (lllllllllll)
produce high levels of Ca2+ influx through voltage-gated ion channels, resulting in exocytosis of
SSVs and release of NT and exocytosis of LDCVs and release of a ‘‘cocktail” of neuropeptides
in a 1:1 ratio. (D) Two different neuropeptides are packaged in LDCVs (red and blue) in a ratio
of 3:1. High levels of neuronal firing (lllllllllll) produce high levels of Ca2+ influx through
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voltage-gated ion channels resulting in exocytosis of SSVs and release of NT and exocytosis of
LDCVs and release of a ‘‘cocktail” of neuropeptides in a 3:1 ratio. Differential regulation of the
biosynthesis and storage of neuropeptides could result in different ratios of neuropeptide release.
If neuropeptide biosynthesis is differentially regulated over the circadian cycle then different
ratios of neuropeptide would be released at different times of day (modified from Albers (2015))
(Albers et al., 2017).
1.8

GABA receptors
GABA receptors are found on most neurons in the mammalian brain (Decavel and Van

den Pol, 1990; Mody and Pearce, 2004). The majority of studies of GABA function have
focused on GABA control of fast, inhibitory actions within the synapse (i.e., phasic activity).
More recently, studies suggest that GABA is capable of a very different type of signaling that
occurs at extrasynaptic sites. GABA receptors found outside of the synapse respond to low
levels of GABA and desensitize much slower than synaptic receptors, placing these receptors in
a position suited to respond to the sustained release of GABA (Lee and Maguire, 2014)(Figure
1.2).
Two major classes of GABA receptors control the cellular response to GABA: GABAA
and GABAB. Both of these classes are found in SCN neurons (Francois-Bellan et al., 1989;
Ulrich and Bettler, 2007; Olsen and Sieghart, 2008; Olsen and Sieghart, 2009; Benarroch,
2012; Albers et al., 2017). GABAARs are ligand-gated ionotropic receptors and contain a
chloride ion pore. GABAB receptors, on the other hand, are metabotropic G-protein-coupled
receptors that, ultimately, signal through Ca2+ and potassium (K+) channels (Ulrich and Bettler,
2007). Interestingly the subunit composition of these receptors appears to determine their
synaptic distribution and pharmacokinetic properties. GABAARs and GABABRs are found on
presynaptic, postsynaptic, and extrasynaptic membranes in the CNS (Benarroch, 2012)(Figure
1.2).
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1.8.1

GABAA receptors
GABAARs are pentameric hetero-oligomers composed of a combination of at least 19,

thus far, identified subunits (Figure 1.4). The subunit composition, as mentioned, fates the
receptor’s pharmacokinetic properties and membrane locations (Rudolph et al., 2001; Vicini and
Ortinski, 2004; Farrant and Nusser, 2005; Olsen and Sieghart, 2008; Belelli et al., 2009;
Winsky-Sommerer, 2009). For example, many reports suggest that GABAARs containing the γ
subunit possess different properties than receptors that contain the δ subunit (Figure 1.4). The
typical composition of the pentameric GABAAR contains two copies of an α subunit, two copies
of a β subunit, and one copy of another subunit. More than 40% of all GABAARs in the brain are
composed of the α1, β2 and γ2 subunits (i.e., 2 α1; 2β2 and 1 γ2) (Chang et al., 1996; Baumann et
al., 2002). Benzodiazepines (BDZs) exert their effects on the GABAAR by binding a pocket
formed by the α and γ subunits, a site distant from the GABA active site (Tan et al., 2011).
GABAARs with the γ subunit are thought to mediate transient inhibitory postsynaptic currents
(IPSCs) and are typically found in the synapse and mediate fast, phasic neurotransmission. As
suggested earlier, a lot of research surrounding GABAA-mediated neurotransmission focuses on
these synaptic, high-affinity GABAA-PHASIC receptors that produce IPSCs with peak and delay
times on the scale of milliseconds, displaying rapid desensitization. These synaptic receptors
typically respond to GABA concentrations at the synapse of more than 1 mM (Mozrzymas et al.,
2003)(Figure 1.4).
In contrast, GABAARs containing the δ subunit are often referred to as GABAA-TONIC
receptors and appear to associate exclusively with specific alpha subunits: α1, α4, and α6 (Jones et
al., 1997; Sur et al., 1999; Glykys and Mody, 2007). Tonic GABAARs are on the plasma
membrane in extrasynaptic locations, respond to low (i.e., ‘tonic’) concentrations of GABA (i.e.,
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0.5-1 µM), and are active longer than typical phasic GABAARs due to lower desensitization and
higher binding affinities (Santhakumar et al., 2006; Lee et al., 2010)(Figure 1.4). Thus, tonic
GABAARs are activated by much lower levels of GABA found outside of the synapse. This tonic
GABA signal can arise by a variety of mechanisms such as synaptic spillover or reversal of
GABA transporters (Yoon and Lee, 2014). These tonic receptors, thus, work on different time
scales and can act independently of synaptic signaling. A gap in our knowledge exists
surrounding the functions and potential interactions of these receptor subtypes within the SCN
and throughout the CNS (Wu et al., 2013).
GABAARs mediate the majority of postsynaptic GABAergic responses in the SCN (Jiang
et al., 1995; Chen and van den Pol, 1998). As described earlier, GABAARs are expressed
throughout the SCN, though some reports suggest more abundance in the vSCN than in the
dSCN (Gao et al., 1995; Belenky et al., 2003). Subcellular studies of GABAAR subunits show
us that GABAARs are on dendritic processes, somata, and in axon fibers and terminals (Belenky
et al., 2003). The majority, however, of GABAAR subunits are found on dendrites in both
synaptic densities as well as extrasynaptic regions of the membrane. However, GABAARs can be
found on presynaptic neurons of the SCN (Belenky et al., 2003).
GABAAR subunit-specific roles in the SCN have been explored with a variety of
approaches. For example, electrophysiological approaches utilize the fact that GABAARs with
αβ subunits are sensitive to zinc (Zn2+), but the γ subunit reduces zinc sensitivity by two-fold
(Draguhn et al., 1990; Smart et al., 1991). Studies employing postnatal rat SCN tissue have
resulted in inconsistent results. One such study shows that SCN GABA-induced inward current
is inhibited by Zn2+ with no potentiation of the response to diazepam, a potent BDZ, as would be
expected in the presence of the γ subunit (Kawahara et al., 1993). Another such study shows that
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diazepam does potentiate GABA-induced currents leading to the conclusion that the SCN
contains γ subunits (Shimura et al., 1996). More recent work in rat SCN tissue shows both zinc
and BDZ responses in the SCN (Strecker et al., 1999;

Kretschmannova et al., 2003;

Kretschmannova et al., 2005). Zn2+ appears to have a greater inhibitory effect in the day,
suggesting a rhythm in the number of GABAARs with the γ subunit. However, no differences in
response to Zn2+ were observed between the vSCN and dSCN.
Other approaches have been used to describe GABAAR subunit mRNA and protein
expression in the SCN. Using microarray technology, transcripts for all 19 currently identified
GABAAR subunits are found in the SCN of mice (Mouse 1.OST SCN 2014 (Pizarro et al.,
2013)). Interestingly, wild type mouse SCN microarray data suggest there is a daily rhythm in γ2
mRNA expression in the SCN, with peak γ2 mRNA at night and low expression during the day
(Pizarro et al., 2013). Although, others have reported that the transcripts for δ and ρ subunits
were not detectable with Northern blot analysis (O'Hara et al., 1995). Since this study, however,
new subunits have been identified (i.e., α6, γ3, ε, π, or θ).
Studies utilizing immunohistochemical techniques show that the SCN contains α2, α3, α5,
β1, β3, γ2, and δ subunits, and possibly others (Naum et al., 2001; Belenky et al., 2003; Walton
et al., 2017). Both transcript and protein levels of some of these subunits are likely rhythmic in
the SCN (Araki and Tohyama, 1992; Gao et al., 1995; O'Hara et al., 1995; Naum et al., 2001;
Walton et al., 2017). Importantly, some work shows that mRNA rhythms may often be
uncoupled from protein rhythms within the SCN. In addition, the presence of subunits does not
necessarily confirm the presence of functional GABAAR subtypes containing the measured
subunits (for a discussion see (Olsen and Sieghart, 2008; Challet et al., 2013)). It will be
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important for future studies to identify the specific subunit composition of functional GABAARs
in the SCN including the distribution patterns and temporal patterns of expression.
1.8.2

GABAAR subunit expression in the SCN
We recently showed different temporal patterns in the expression of δ and γ2 subunit

mRNA and protein-IR across all subregions of the SCN(Walton et al., 2017). These findings
suggest that GABAA-TONIC extrasynaptic receptors and GABAA-PHASIC synaptic receptors
are differentially regulated within the SCN (Figure 1.4). While δ-subunit protein levels did not
change across the circadian cycle, γ2-subunit protein displayed rhythmicity in the SCN of
hamsters housed in LD and DD. These findings suggest that this protein may be regulated by the
circadian pacemaker and be tuned by environmental light. In hamsters housed in DD, the amount
of γ2-subunit protein varied significantly over the circadian cycle with peak levels occurring
during the subjective day. In LD, the γ2-subunit protein also varied, with lowest levels during the
light phase, suggesting that environmental light may inhibit γ2 protein levels. The possibility that
δ protein levels are also inhibited by light cannot be excluded because the lower levels of this
protein-IR seen during the light phase in LD approached, but did not reach, statistical
significance. In addition, hamsters housed in LD showed reduced protein-IR for both γ and δ
subunits as compared with hamsters housed in DD, an effect that was strongest in the vSCN
(Walton et al., 2017). These data suggest that GABAARs containing the δ subunit (i.e.,
extrasynaptic GABAA-TONIC receptors) remain relatively constant across time but the circadian
pacemaker regulates GABAARs containing the γ2 subunit (i.e., synaptic GABAA-PHASIC
receptors). Furthermore, both receptor subunits may be responsive to environmental light. As
mentioned, the presence of GABAAR subunits does not indicate the presence of functional
receptors. Concurrent measures of tonic and phasic currents within neurons of the SCN at
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different times of the day will be necessary to further support this possibility (Olsen and
Sieghart, 2008).
Interestingly, we also found that the ratio of δ to γ2 subunit protein changes across the
circadian cycle in a region-specific manner. Specifically, the ratio of δ to γ2 protein-IR was
greater during the night than during the day but only in the subregion of the SCN that
corresponds to the retinorecipient (vSCN) area of the nucleus (Walton et al., 2017). These data
suggest that within this region the δ subunit containing extrasynaptic GABAA-TONIC receptors
may play a larger role in mediating the response to GABA than the γ2 containing synaptic
GABAA-PHASIC receptors during the night, while the opposite is true during the day. If
GABAARs within the retinorecipient SCN mediate the ability of GABA to alter circadian phase,
then GABA agonists that act selectively on extrasynaptic GABAA-TONIC receptors would be
predicted to be more efficacious in modulating phase shifts during the night while agonists that
act selectively on synaptic GABAA-PHASIC receptors would be predicted to be more effective
during the day. Behavioral experiments from our lab and work in other labs support this
hypothesis (Ehlen and Paul, 2009; McElroy et al., 2009). Injection of [4,5,6,7-tetrahydroisoxazolo [5,4-c] pyridine-3-ol] (THIP), an extrasynaptic δ-containing receptor super agonist,
into the SCN region, inhibits the phase shifting effects of light at night but has no effect on
circadian phase during the day, and diazepam, a benzodiazepine that acts on γ2 subunit
containing GABAARs phase shifts circadian rhythms during the day but does not influence
circadian phase at night (Walton et al., 2017). Muscimol, on the other hand, a more promiscuous
agonist of both extrasynaptic and synaptic GABAARs, influences circadian phase during both the
day and night. However, it is important to interpret these studies with caution, as the
pharmacological actions of these drugs are often complex (see Albers, et al., 2017 for a review).
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Nevertheless, the increase in the ratio of δ to γ2 receptor protein within the retinorecipient SCN
could indicate a shift in the balance of GABA’s effects from synaptic (i.e., phasic) modulation
during the subjective day to extrasynaptic (i.e., tonic) modulation during the subjective night.
These findings highlight the complex role of GABA in the SCN across the circadian cycle; and
also suggest the need for further work to identify the subunit composition, anatomical
distribution, temporal, and regulatory factors influencing the expression and function of
GABAARs in the SCN (Figure 1.4).

Figure 1-4: Synaptic and extra-synaptic GABA receptors
Synaptic GABAA-PHASIC receptors are characterized by the presence of a γ subunit and
respond to presynaptically released saturating concentrations of GABA (>1 mM). These
receptors can produce inhibitory postsynaptic currents that peak and decay within milliseconds
and rapidly desensitize. Benzodiazepines (BDZs) are thought to bind in the pocket formed by the
α and γ subunits. Extra-synaptic GABAA-TONIC receptors are characterized by the presence of a
δ subunit and respond to non-saturating GABA concentrations (0.5–1.0 µM). These receptors are
activated for long intervals because they display low levels of desensitization. Ethanol and
steroids are thought to bind in the pocket formed by the α and δ subunits (Albers et al., 2017).
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1.9

SCN GABA: acute and sustained effects
As described earlier, an important function of the SCN is the ability to entrain an

organism’s physiology and behavior with the day-night cycle. Two theories have led to intensive
investigation and discussion for over 50 years into how light entrains circadian pacemakers (for a
review see (Aschoff, 1960; Pittendrigh, 1960; Roenneberg et al., 2010). The “parametric”
theory proposes that pacemakers entrain to the day-night cycle by light acting in a sustained
manner constantly altering the pacemaker’s speed (i.e., altering the state variables of the clock).
An alternative hypothesis that many have used to test the function of circadian clocks is the
“non-parametric” theory. This theory suggests the phase of the circadian pacemaker is
instantaneously shifted by acute changes in light. Many modern researchers still employ these
theories but also have moved on from them suggesting that light causes both acute and longlasting changes to the pacemaker. Due to the success of the non-parametric theory in predicting
the properties of entrainment, as well as the relative ease of presenting and measuring short
duration events, much research on the mechanisms controlling light-induced phase shifts of the
SCN has focused on acute rather than sustained neurochemical processes (Pittendrigh and Daan,
1976a). However, increasing evidence shows that sustained neurochemical events are critical in
understanding how light phase shifts the pacemaker.
Photic stimuli elicit transient responses and sustained responses in the SCN. The
transient responses to light, including NMDA receptor activation by glutamate release from the
RHT, leads to a cascade of sustained responses in the SCN that ultimately result in a phase shift.
Analyses include an in vivo study of the sustained response in hamsters given light pulses at
times that produce phase shifts and in vitro studies using slices prepared from transgenic mice
given light pulses at times that produce phase delays or advances (Hamada et al., 2001;
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Kuhlman et al., 2003; LeSauter et al., 2011). In brief, the response to light includes neuronal
firing changes and the induction of period gene expression in the vSCN that begin 30-60 minutes
after the light pulse and persists for at least 4-5 hours. The application of other neurotransmitters
involved in phase shifting the clock (i.e., VIP or GRP) also produces a light-like persistent
increase in neural activity (Gamble et al., 2007; Gamble et al., 2011; Kudo et al., 2013). After
this initial sustained response begins in the vSCN, Per expression increases in the dSCN
approximately 90 minutes after the light signal. This upregulation of Per expression is necessary
for long-term increases in excitability (Kuhlman et al., 2003;

Gamble et al., 2007). The

following sections will review the acute actions of GABA-active drugs on light-induced phase
shifts as well as the role of GABA during the sustained response to light.
1.9.1

Acute, systemic administration of GABA-active drugs
Early evidence that GABA-active drugs influence entrainment of circadian rhythmicity

was the finding that systemic administration of benzodiazepines accelerates re-entrainment to
phase shifts of the light/dark cycle (Davies et al., 1974; Childs and Redfern, 1981). Others
showed that systemic injection of GABA-active drugs during the subjective night alters the
phase shifting effects of light (Ralph and Menaker, 1985; Ralph and Menaker, 1986; Ralph and
Menaker, 1989;

Golombek and Ralph, 1994). For example, the GABAAR antagonist

bicuculline, when intra-peritoneal (i.p.) injected immediately prior to a brief light pulse, blocks
the ability of light to induce phase delays in the early subjective night but not light-induced
advances in the late subjective night (Ralph and Menaker, 1985). Furthermore, neither THIP, a
GABAAR agonist specific for receptors containing the δ subunit, nor diazepam reduces the phase
delaying effects of light (Ralph and Menaker, 1986). However, both drugs reduce the ability of
bicuculline to inhibit the phase delaying effects of light (Ralph and Menaker, 1989). Vigabatrin,
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a drug that increases GABA levels by inhibiting GABA transaminase, increases photic phase
delays but not advances (Golombek and Ralph, 1994). These early findings suggest that GABA
works differently for phase advances and delays, which may relate to differences in subunit
composition of GABAARs. As discussed in Chapter 2, these differences could also be due to
whether GABA is inhibiting or exciting SCN neurons. The systemic administration of
bicuculline and diazepam inhibit light-signaled delays and advances, respectively, but neither
treatment inhibits light induction of Fos protein within the SCN (Colwell et al., 1993)(Table
1.1). These data show that acute systemic administration of GABA-active drugs administered
before light exposure can have profound effects on the entrainment of circadian rhythms through
effects on light-signaled phase shifts. These earlier findings using systemic injection also suggest
that GABA-active drugs have a potential for therapeutic effects on circadian disorders.
Table 1-1: Circadian effects of systemic and intra-SCN GABAergic injections

1.9.2

Acute effects of GABA-active drugs into the SCN region
Work from our lab and from others utilizes the administration of some of these same

GABA-active drugs directly into the SCN region (Table 1.1). The activation of GABAARs in the
SCN just before light exposure robustly inhibits the ability of light to phase shift the circadian
pacemaker in both night-active and day-active rodents. Microinjections of the GABAAR agonist
muscimol into the SCN before a light pulse in the early subjective night inhibits light-induced
phase delays in the adult male Syrian hamster (Gillespie et al., 1996; Gillespie et al., 1997).
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Muscimol also decreases phase delays produced by the microinjection of a cocktail containing
the neuropeptides VIP, PHI and GRP early in the subjective night. As in the night-active Syrian
hamster, muscimol inhibits light-induced phase delays in the early subjective night in day-active
grass rats, suggesting a common GABAergic mechanism for phase delays to light (Novak and
Albers, 2004a). Injection of the GABAAR antagonist bicuculline directly into the SCN region of
Syrian hamsters before a phase-delaying light pulse or a mixture of VIP/PHI/GRP enhances the
phase delays induced by light or cocktail (Gillespie et al., 1996; Gillespie et al., 1997).
In the late subjective night, when light pulses lead to phase advances, the microinjection
of muscimol directly into the SCN of the Syrian hamster reduces the magnitude of the phase
advance in both hamsters and day-active grass rats, suggesting an acute inhibitory role of
GABAAR activation on phase advances (Gillespie et al., 1997; Novak and Albers, 2004a).
Interestingly, and in contrast with phase delays, the GABAAR antagonist bicuculline before a
phase advancing light pulse in the late subjective night does not increase the phase advance in
Syrian hamsters. THIP, a δ subunit-containing GABAAR super agonist, injection into the SCN
before phase delaying or advancing light pulses mimics the ability of muscimol to inhibit these
phase shifts, suggesting a role in this process for GABAA-TONIC receptors (Ehlen and Paul,
2009).
Presently, the mechanisms by which GABAAR agonists inhibit the phase shifting effects
of light are unknown. One possibility is that presynaptic GABAARs inhibit glutamate release
from RHT terminals. It is also possible that these agonists act on postsynaptic neurons to inhibit
the response to activation of glutamate receptors, likely in the retinorecipient SCN. There is no
evidence for presynaptic GABAARs on RHT terminals, though pre-synaptic GABAARs do exist
in the SCN (Belenky et al., 2003). As muscimol acutely inhibits the phase shifting effects of
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NMDA when administered directly into the SCN, it is likely that these effects are via a
postsynaptic action (Mintz et al., 2002b).
To shift the clock, light must ultimately shift the molecular clock. Light-induced phase
shifts increase Per1 and Per2 gene expression within the SCN (Albrecht et al., 1997; Shearman
et al., 1997; Shigeyoshi et al., 1997; Horikawa et al., 2000; Albrecht et al., 2001). Therefore it
is possible that GABA inhibits light-induced phase shifts by ultimately reducing or blocking this
increase in the expression of Per1 and Per2. For example, muscimol injected into the SCN
region before a phase delaying light pulse reduces Per1 but not Per2 mRNA levels in the SCN.
In contrast, muscimol administered before a phase advancing light pulse reduces Per2 but not
Per1 mRNA increases (Ehlen et al., 2008). Interestingly, muscimol injected into the SCN region
of the day-active grass rat before a phase delaying light pulse reduces Per2 but not Per1 mRNA
levels in SCN, suggesting a possible difference between day and night-active species (Novak et
al., 2006). This also elucidates a difference in period gene and behavioral effects of muscimol
administration in that muscimol reduces light-induced behavioral phase delays in both nightactive hamsters and day-active grass rats, but muscimol has different effects on period genes in
that it reduces Per1 but not Per2 mRNA in hamsters and reduces Per2 but not Per1 mRNA in
grass rats. The GABAA-TONIC receptor agonist, THIP, significantly inhibits Per1 and Per2
mRNA when injected in to the SCN of the Syrian hamster before a phase-delaying light pulse in
the early subjective night but only Per1 mRNA when injected before a phase-advancing light
pulse in the late subjective night (Ehlen and Paul, 2009).
1.9.3

GABA in day-active species
Unfortunately, experiments of the mechanisms responsible for phase shifting mammalian

circadian pacemakers have been almost exclusively performed in night-active species (Challet,
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2007). GABAAR-active drugs have been shown to induce phase shifts in the subjective day in
two day-active species. For example, systemic injection of triazolam in the day induces phase
advances in the day-active squirrel monkey as it does in night-active rodents (Mistlberger et al.,
1991). In contrast, muscimol injection into the SCN of the day-active Nile grass rat has the
opposite effect; it induces phase delays (Novak and Albers, 2004a; Novak and Albers, 2004b).
In addition, a subjective day light pulse in night-active animals inhibits the phase advancing
effect of muscimol, while the phase delaying effects of muscimol in day-active animals is not
blocked by light (Mintz et al., 2002b; Novak and Albers, 2004b). Thus, activation of GABAARs
in the subjective day produces the opposite response in a day-active and night-active rodent.
GABAAR activation with a GABAAR agonist in the middle of the subjective day also
alters the expression of the clock genes Per1 and Per2. Injection of the promiscuous GABAAR
agonist muscimol into the Syrian hamster SCN during the middle of the subjective day produces
phase advances, as shown by multiple reports, and suppresses Per1 mRNA and Per2 mRNA
(Ehlen et al., 2006; Ehlen et al., 2008). Systemic administration of the BDZ brotizolam, like
muscimol, also induces phase advances during the subjective day and suppresses both Per1 and
Per2 mRNA levels in the hamster SCN (Yokota et al., 2000). It is a different story in the dayactive Nile grass rat. Injection of muscimol into the SCN of the grass rat during the middle of the
subjective day produces phase delays and decreases Per2 mRNA but not Per1 mRNA (Novak et
al., 2006). It is not known if the suppression of these core clock genes leads to the phase
advances and delays observed in these rodents, though an interaction would be likely. Others
have shown, however, that although suppression of Per1 is sufficient to induce phase advances
this interaction between daytime muscimol phase advances and the molecular clock is not so
straightforward (Hamada et al., 2004b; Ehlen et al., 2008).
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1.9.4

Sustained activation of GABAARs in the SCN during the night
As described, long term changes in period gene expression and firing in the SCN occur

after the receipt of a light pulse. The sustained activation of GABAARs, in contrast to the
inhibition of light-induced phase delays by acute activation of GABAARs with muscimol, may
be an important part of the signaling pathway mediating the phase delaying effects of light. As
reviewed above, the receipt of a light pulse via the RHT leads to a sustained increase in firing in
the SCN that lasts four or more hours. As GABA is produced in nearly all SCN neurons, it seems
likely that this sustained increase in firing could lead to a concurrent sustained synaptic release
of GABA from SCN neurons (van den Pol and Gorcs, 1986; Moore and Speh, 1993). This
sustained release of GABA could, therefore, activate synaptic GABAA-PHASIC receptors and,
due to spillover, also activate extrasynaptic GABAA-TONIC receptors. We tested this “sustained
hypothesis”, that long duration (4 or more hours) activation of GABAARs in the SCN mediates
the ability of light to phase delay the circadian clock, by administering GABAAR agonists and
antagonists over an extended period of time in the subjective night (Hummer et al., 2015). We
found that the sustained administration of muscimol into the SCN over four or more consecutive
hours beginning in the early subjective night induces large phase delays. This treatment is not
effective when muscimol is administered over one, two, or three hour intervals (Figure 1.5).
These effects are dose-dependent and different injection protocols were used to determine that
the duration and not the phase of muscimol administration was the critical component for the
induction of phase delays (Figure 1.6). Further support for the “sustained hypothesis” was
found by demonstrating that the sustained pharmacological antagonism of GABAARs inhibits
light-induced phase delays of the circadian pacemaker. The sustained administration of
bicuculline, for six or more hours beginning between one and four hours after the light pulse (CT
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13.5), significantly reduces light-induced phase delays. In contrast, sustained administration of
bicuculline for six hours beginning well after the light pulse (i.e., 10 hours- CT 23.5) does not
inhibit light-induced phase delays. We also found that administration of bicuculline for 3, or 4
hours, in different temporal patterns between CT 14.5 and CT 21.5, does not inhibit lightinduced phase delays. This suggests there is not a critical phase of GABAAR activation by
endogenous GABA release necessary for the induction of phase delays. These findings do agree
with the muscimol data in that there appears to be a critical duration (Figure 1.6). Furthermore,
when a 2-hour window between CT 14.5 and CT 21.5 interrupts 6 hours of bicuculline injection,
the GABAAR antagonist does not block light-induced phase delays. Importantly, a bolus
injection of the total of the 4 doses used did not lead to phase delays of the rhythm, suggesting
the total concentration was not as important as the sustained fashion of administration. These
data support the “sustained hypothesis” in that the sustained activation of GABAARs in the
SCN is sufficient and necessary for light to phase delay the circadian pacemaker (Hummer et
al., 2015)(Figure 1.6).
These data suggest that the circadian pacemaker in the SCN is not ‘instantaneously’
phase shifted by light, but requires hours of GABAAR activation to result in a phase delay of
the pacemaker. When considered using the classic theories of entrainment put forth by
stalwarts in the circadian field (i.e., Aschoff and Pittendrigh), these findings do not support the
theory of non-parametric entrainment. These GABA studies suggest that light pulses are
transduced into a sustained activation of the pacemaker, which must last hours to lead to a
phase delay. When considered in light of the parametric theory of entrainment, the sustained
effects of activation of GABAARs are not as clear. For instance, no relationship was observed
between the duration of GABAAR activation and the magnitude of phase shifts, which one
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would assume if considering the parametric theory. However, a negative relationship was
observed between the duration of bicuculline administration and the magnitude of phase shifts
(Hummer et al., 2015). Current researchers recognize that neither theory can predict all
circadian responses to light. This has led to the development of new concepts of entrainment
that may ultimately prove effective at explaining the neurobiological processes underlying the
most important clock function of entrainment (Johnson et al., 2003; Roenneberg et al., 2010).
The mechanisms through which sustained activation of GABAARs lead to phase delays
within the SCN are unknown. As described earlier, the vSCN receives the majority of retinal
input via the RHT and a higher percentage of dSCN neurons display prominent circadian
oscillations than in the vSCN. It is possible, due to the sustained effects of light on the SCN, that
light induces release of GABA from activated neurons in the vSCN for four or more hours and
this GABA release communicates new phase information via its connections to the dSCN,
ultimately phase shifting the entire pacemaker (Albus et al., 2005; LeSauter et al., 2011; Albers
et al., 2017).
More recent modeling studies about tonic “sustained” GABA release within the SCN also
lend some support to the “sustained hypothesis” (DeWoskin et al., 2015). The tonic release of
GABA may be a function of membrane potential. More specifically, if hyperexcited and
depolarized SCN neurons release tonic (extrasynaptic/low desensitization) levels of GABA over
approximately five hours, this release of GABA can phase shift the SCN, even in the absence of
action potentials. In vitro studies show that subpopulations of SCN neurons can spontaneously
achieve such a hyperexcited state in the middle of the subjective day. This time of day
corresponds to the time GABA release is predicted to be high by the model (Belle et al., 2009;
DeWoskin et al., 2015). While sustained GABA release at this time of day (CT 3-8) is unlikely
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to mediate the phase delaying effects of light in the early subjective night, it has been suggested
that a hyperexcited state leading to sustained GABA release may be induced by long lasting
glutamate release during light input at other times of day (DeWoskin et al., 2015). Furthermore,
it appears that this hyperexcited state is restricted to Per1 containing neurons. Importantly, Per1
expression is associated with the induction of phase delays by light in the early subjective night.
In summary, these modeling and in vitro studies suggest that glutamate release induced by light
around CT 13.5 may stimulate a hyperexcited state in the intact SCN and downstream sustained
GABA release that activates GABAARs leading to a phase delay of the pacemaker.
Further work is certainly needed in order to define the role of sustained GABAAR
activation in phase delaying the pacemaker. The simplest proposition is that GABAARs,
expressed on rhythmic SCN clock cells of the dSCN, respond to a sustained release of GABA
from retinorecipient neurons in the vSCN. It is also possible that rhythmic neurons in the core
respond directly or indirectly to light, and interactions between the component oscillators in the
core and shell are responsible for the light-induced phase delay. The idea that sustained
GABAAR signaling could adjust the period of the dSCN and/or coupling of the dSCN and vSCN
is supported by data from both empirical and modeling studies (Albus et al., 2005; Evans et al.,
2013; DeWoskin et al., 2015; Myung et al., 2015b). The subunit compositions of GABAARs
that mediate the sustained activation necessary for the phase delaying effects of light are
unknown. However, GABAA-TONIC receptors are a likely candidate due to low levels of
desensitization and extrasynaptic expression on the membrane. These data combined with our
findings about the changes in tonic GABAAR subunits suggest the hypothesis that the sustained
effects of GABA on phase shifts of the SCN at night may be mediated by extrasynaptic GABAATONIC receptors. Further experiments are necessary to determine which functional GABAAR
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subtypes respond to the sustained release of GABA on photic phase shifts, or if both tonic and
phasic receptors play a role in this process.
These very same modeling studies also suggest that SCN neurons excited, not inhibited,
by GABA may mediate these tonic phase shifting effects (DeWoskin et al., 2015). Thus, it will
be important to determine whether the ratio of GABA excitation: inhibition in the SCN plays a
role in phase shifting the pacemaker (See Chapter 2). Whether GABA excites or inhibits a
neuron largely depends on chloride gradients as maintained by chloride co-transporters (See
Chapter 2).

Figure 1-5: The sustained administration of muscimol
The sustained administration of muscimol for at least 4 h is necessary to induce light-like
phase delays in Syrian hamsters. (A) Injection regimen used to determine the duration of
GABAA receptor activation necessary to induce a phase delay. All groups received a series of 4
hourly injections into the suprachiasmatic nucleus (SCN) region between circadian time CT13.5
and CT16.5. However, the number of consecutive injections containing muscimol (21.9 mM)
varied from 0 to 4 (VEH = vehicle; MUS = muscimol). (B) Mean ± SE of phase delays produced
by the 5 treatments outlined in A (* vs. 0 muscimol injections, p = 0.002). (C and D)
Representative activity records demonstrating the effect of 4 hourly injections of vehicle (C) or
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muscimol (21.9 mM) (D) into the SCN region between CT13.5 and CT16.5 on locomotor
rhythms in DD. Bars depict the 4-h injection period (white: saline; red: muscimol) (modified
from Hummer et al., 2015)(Albers et al., 2017).

Figure 1-6: Summary of sustained effects of GABA
Summary of the effects of over 1700 injections containing muscimol, bicuculline, or
vehicle into the SCN region on the phase of circadian locomotor rhythms in Syrian hamsters. (A)
Solid red bar indicates the timing of SCN injections in which muscimol induces a significant
phase delay in the locomotor rhythm. Open red bars indicate the timing of SCN injections of
muscimol that did not produce significant phase delays. (B) Solid blue bars indicate the timing of
SCN injections in which bicuculline significantly inhibits light-induced phase delays. Open blue
bars indicate the timing of SCN injections of bicuculline that do not significantly inhibit lightinduced phase delays. Yellow bar indicates the timing of the 15-min light pulse. (C) Proposed
sequence of neurochemical events within the SCN necessary for a light pulse to induce a phase
delay. Light induces release of glutamate (GLU) that activates NMDA receptors within the SCN
for seconds and possibly minutes (initial transient response). The transient responses to light
induce activity in non-rhythmic SCN neurons that begins 30–60 min after the light pulse
resulting in the sustained release of GABA for 6 or more hours. The sustained GABA release
from non-rhythmic neurons results in the sustained activation of GABAA receptors on rhythmic
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SCN neurons, producing a phase delay in the pacemaker (from Hummer et al., 2015)(Albers et
al., 2017).
1.10 Non-photic stimuli and phase shifts of the SCN
Stimuli, other than light, can also phase shift the circadian pacemaker. These stimuli are
often referred to as “non-photic” phase shifting stimuli. An early demonstration that non-photic
stimuli could phase shift the circadian clock was shown with direct injection of NPY-like
neuropeptides into the SCN (Albers and Ferris, 1984; Albers et al., 1984; Huhman and Albers,
1994). NPY-like neuropeptides produce a pattern of phase shifts that drastically differ from the
phase response curve to light in that NPY produces large phase advances during the subjective
day and small phase delays in the late subjective night (Figure 1.7). A similar pattern of phase
shifts is observed when NPY is administered in vitro (Medanic and Gillette, 1993; Golombek et
al., 1996;

Harrington and Schak, 2000). Some non-photic phase shifting stimuli act by

increasing locomotor activity and arousal, although more work is needed to understand the
biological substrates mediating these shifts. Other examples of non-photic stimuli that lead to
phase shifts are spontaneous activity on a novel running wheel, three hours of gentle handling, as
well as saline injections (Mrosovsky, 1995; Hastings et al., 1998; Yannielli and Harrington,
2004; Yannielli et al., 2004). It has been shown that NPY, however, does not lead to phase shifts
by increases in arousal (Biello et al., 1994; Mrosovsky, 1995).
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Figure 1-7: Photic and non-photic phase response curves
Comparison of the phase shifting effects of ‘‘photic” (solid red line) and ‘‘non-photic”
stimuli (dotted black line) presented to nocturnally active rodents housed in constant darkness.
Light does not produce phase shifts until the late subjective day and early subjective night when
it produces phase delays. Later in the subjective night light produces phase advances. Non-photic
stimuli, such as injection of neuropeptide Y into the suprachiasmatic region, induce large phase
advances during the subjective day and smaller phase delays in the subjective night. Note: not all
‘‘non-photic” phase shifting stimuli produce a pattern of phase shifts like those seen in this
figure. In nocturnal rodents the subjective day refers to the inactive phase and the subjective
night refers to the active phase of the circadian cycle. Circadian time 12 is designated as the time
of locomotor onset (modified from Webb et al., 2014) (Albers et al., 2017).
1.10.1 GABAARs and non-photic shifts of the pacemaker
A role for GABAARs in non-photic phase shifts was first shown by the finding that
systemic administration of short acting BDZs (i.e., triazolam, midazolam, brotizolam) as well as
the GABAAR agonist muscimol produced patterns of phase shifts similar to the shifts induced by
injection of NPY-like neuropeptides into the SCN (Turek and Losee-Olson, 1986; Ebihara et al.,
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1988; Wee and Turek, 1989; Yokota et al., 2000; Vansteensel et al., 2003). Like some other
non-photic stimuli, phase shifts produced by triazolam also result from an induction of locomotor
activity as immobilization following triazolam administration blocks the phase shifts (Van Reeth
and Turek, 1989). In contrast, systemic injection of the long-acting BDZ chlordiazepoxide
induces ‘NPY-like’ patterns of phase shifts without induction of locomotor activity (Biello and
Mrosovsky, 1993; Meyer et al., 1993)(Figure 1.7). Thus, some BDZs lead to phase shifts by
increasing locomotor activity but increased activity is not necessary for the phase shifts produced
by all BDZs.
GHT mediated NPY release within the SCN has been shown to mediate the phase
shifting effects of a variety of non-photic stimuli (Mrosovsky, 1995; Mrosovsky, 1996). Lesions
of the GHT decrease the ability of systemically administered BDZs to induce phase shifts
(Johnson et al., 1988b; Biello et al., 1991; Meyer et al., 1993). BDZs were also shown to inhibit
neuronal firing of SCN neurons and phase shift the single unit firing rhythm in vitro (Liou et al.,
1990; Mason et al., 1991; Strecker et al., 1999; McElroy et al., 2009). Thus, BDZs may act in
the SCN as well as at other sites to lead to the induction of phase shifts.
Muscimol activation of SCN GABAARs during the subjective day causes large phase
advances whether administered in vivo or in vitro in night-active species (Smith et al., 1989;
Smith et al., 1990; Tominaga et al., 1994; Huhman et al., 1995; Huhman et al., 1997; Bergeron
et al., 1999; Mintz et al., 2002b; Gamble et al., 2003; Ehlen et al., 2006; Ehlen et al., 2008;
Biello, 2009; Walton et al., 2017). In contrast, muscimol administration in the late subjective
night produces small phase delays in vivo but not when using in vitro models. A light pulse or
injection of NMDA during the subjective day blocks muscimol-induction of phase advances
(Mintz et al., 2002b; Gamble et al., 2003). TTX blocks the reduction of muscimol-induced
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advances by NMDA (Gamble et al., 2003). Thus, synaptic activity is necessary for the
communication of photic information within the SCN during the day. In contrast to the advance
caused by the GABAAR agonist muscimol in the subjective day, the injection of THIP, a drug
described as a GABAA-TONIC receptor super-agonist, into the SCN does not induce phase
advances in vivo during the subjective day (Ehlen and Paul, 2009). However, in vitro application
of diazepam, a GABAA-PHASIC receptor agonist, does induce phase advances (McElroy et al.,
2009). Thus, it is possible that the phase shifting effects of muscimol during the subjective day
in the SCN are mediated by GABAA-PHASIC receptors.
The similarities in the PRCs produced by activation of GABAARs and NPY receptors
suggest that similar mechanisms could mediate their phase shifting effects. Support for this
hypothesis is the finding that the GABAAR antagonist bicuculline blocks the ability of NPY to
induce phase advances in vivo (Huhman et al., 1995). Bicuculline also blocks NPY-induced
phase advances in multiple unit activity in vitro but does not block NPY-induced phase advances
in extracellular single unit recordings (Biello et al., 1997; Gribkoff et al., 1998). In vivo studies
show that Na+-dependent action potentials in the SCN are necessary for NPY, but not muscimolinduced phase advances. Thus, it is possible that the phase shifting effects of NPY are mediated
by the release of GABA within the SCN (Huhman et al., 1997). In vitro studies, however, show
that neither muscimol nor NPY-induced phase advances in extracellular single unit recordings
require Na+-dependent action potentials (Biello et al., 1997; Bergeron et al., 1999). Although not
consistent across studies, a parsimonious conclusion is that GABAAR activation in the SCN
mediates the induction of shifts by non-photic stimuli. We extend this idea to test the role of
GABA-induced excitation in these non-photic shifts in the subjective day (Chapter 2).
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1.11 Cellular responses to GABA in the SCN
The results of the studies of the cellular actions of GABA using GABAAR and GABABR
specific agonists and antagonists are complex and there is not a consensus as to the role of
GABA in the functions of the SCN (For extensive analysis see Tables 3-5 from (Albers et al.,
2017)). One possibility that may explain the differences in observed effects is the varied methods
used to record the cellular responses to GABA and GABA-active drugs. Most of this work has
utilized in vitro preparations coupled with a variety of electrophysiological techniques (e.g.,
multiple unit recordings, patch clamp, etc.), measurements of intracellular Ca2+ concentrations,
and measurement of the mRNA and protein products of key SCN genes. In most cases, these
studies have examined the acute but not the sustained changes in cellular activity in response to
manipulation of GABA in the SCN.
The cellular effects of GABA are inconsistent across studies even when very similar
techniques are used. The reasons for these inconsistencies deserve further attention. One example
is that in studies employing whole cell and patch clamp recordings, excitatory responses to
GABA may be masked by the use of high chloride concentrations thereby enforcing inwardly
directed chloride currents (Wagner et al., 1997). Considering these differences, researchers found
it important to not only consider the inhibitory role of GABA within the SCN but to consider the
excitatory effects of GABA (Choi et al., 2008; Irwin and Allen, 2009).
1.12 GABA excitation
Although GABA is most commonly viewed as the primary inhibitory neurotransmitter in
the CNS, in vitro studies suggest the presence of excitatory GABA responses in the adult SCN,
though, to our knowledge, no in vivo studies in the SCN exist (Wagner et al., 1997; De Jeu and
Pennartz, 2002; Choi et al., 2008; Irwin and Allen, 2009). However, a consensus has not been
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reached, with reports of excitatory responses to GABAAR binding reported in the day, in the
night, or not at all. Despite the controversy in circadian biology, there is now substantial
evidence, in many brain regions, that the actions of cation chloride cotransporters (CCC) are
critical in determining whether GABA is hyperpolarizing or depolarizing in the immature and
mature brain (Markadieu and Delpire, 2014)(Figure 1.8). The hypothesis that phase-dependent
GABA mechanisms are important in controlling the responsiveness of the circadian system to
light is not a new one, but little investigation has focused on the role of chloride gradient
maintenance by chloride cotransporters.

Figure 1-8: Excitatory and inhibitory effects of GABA
Mechanisms underlying the excitatory and inhibitory effects of GABA on neuronal
activity. In neurons that are depolarized and thus excited by GABA, NKCC1 transporters are
more abundant than KCC2 transporters, resulting in higher levels of intracellular chloride (Cl-)
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than extracellular Cl- (left, top). Upon GABAAR channel opening, the efflux of negatively
charged chloride ions produces depolarization of the neuron (left, bottom). In neurons that are
hyperpolarized and thus inhibited by GABA, KCC2 transporters are more abundant than NKCC1
transporters resulting in lower chloride in the neuron relative to chloride outside the neuron
(right, top). Upon GABAAR channel opening, negatively charged chloride ions entering the
neuron cause hyperpolarization of the neuron (right, bottom) (Albers et al., 2017).
1.13 Chloride and chloride cotransporters (CCCs)
Most mature neurons maintain low intracellular chloride concentration ([Cl-i]) (Kaila,
1994; Payne, 2009). However, there is a high metabolic cost associated with this low chloride
state, a cost that is apparent during seizures or strokes (Hansen, 1985; Kaila et al., 2014). A
major role for CCCs in mature neurons is setting the reversal potential (Erev) and driving force
(DF) on anion currents through GABAARs and glycine receptors (GlyRs), as well as on nonligand gated inward-rectifying chloride channels (Blaesse et al., 2009; Rinke et al., 2010).
Chloride cotransporters (CCCs) are glycoproteins with a molecular weight between 110-140 kDa
and consist of 12 transmembrane segments with intracellular amino and carboxy terminals
(Gamba, 2005; Payne, 2012). The tertiary structures are not known, but some researchers
suggest that the quaternary structure of CCCs may consist of dimers (Payne, 2012). CCCs are
expressed in all organ systems and in addition to chloride gradient control in neurons, CCCs also
regulate cell volume, transepithelial ion transport, neuroendocrine signaling, and blood pressure
(Russell, 2000; Payne et al., 2003; Gamba, 2005; Blaesse et al., 2009; Gagnon and Delpire,
2013;

Kim et al., 2013;

Inoue and Bains, 2014). There are two branches of the CCC

phylogenetic tree; a Na+- dependent and Na+-independent branch (Gagnon and Delpire, 2013).
NKCC1, NKCC2, and NCC are Na+-dependent secondary active transporters as they are
indirectly dependent on the inward Na+ gradient maintained by Na+/K+ ATPase, while KCCs
are Na+-independent. Following is a brief overview of the CCCs mediating chloride efflux
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(KCCs) and the main CCC regulating chloride influx (NKCC1) in the CNS, the protein studied
in this project.
1.13.1 KCC Overview
K+/Cl- cotransporters (KCCs) regulate Cl- efflux powered by an outward K+ gradient with
4 identified isoforms (KCC 1-4) (Gamba et al., 1994; Clayton et al., 1998; Blaesse et al., 2009;
Lucas et al., 2012; Mao et al., 2012). KCC3 is expressed in the peripheral and central nervous
systems. KCC2 is the major chloride efflux protein in neurons and it promotes fast
hyperpolarizing inhibition. It is found in most central neurons and shows very low expression in
the PNS (Payne et al., 1996; Rivera et al., 1999; Li et al., 2002; Blaesse et al., 2009; Gagnon
and Delpire, 2013). KCC2 is the only KCC isoform not expressed in glia (Gagnon et al., 2007).
KCC2 produces two N-terminal splice variants, a and b. Kcc2b is up regulated quickly after birth
in mice and rats and represents 90% of total Kcc2 mRNA in the adult mouse cortex (Kanaka et
al., 2001; Gulacsi et al., 2003; Bartho et al., 2004; Uvarov et al., 2007; Sun et al., 2012b).
1.13.2 KCC2 changes during development
The up-regulation of KCC2 during development is involved in mechanisms of neuronal
differentiation (Song 2002, Talos 2012, Horn 2010) and KCC2 expression organizes in a caudal
to rostral pattern in the developing CNS (Li et al., 2002; Song et al., 2002; Wang et al., 2002;
Stein et al., 2004; Horn et al., 2010). KCC2 expression drastically increases during the first
postnatal month in rodents whereas in humans, KCC2 begins to increase during gestation (Li et
al., 2002; Vanhatalo et al., 2005; Bayatti et al., 2008; Horn et al., 2010; Puskarjov et al.,
2014a;

Puskarjov et al., 2014b) Some work demonstrates that BDNF, through its TRKB

receptor, promotes this developmental up-regulation of mRNA encoding Kcc2b (Aguado et al.,
2003;

Ludwig et al., 2011). KCC2 is the CCC predominantly responsible for controlling
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chloride efflux in neurons and its paucity early in rodent development is thought to be
responsible for depolarizing GABAAR responses resulting from high [Cl-i], though these
responses are also NKCC1-dependent (Pfeffer et al., 2009; Sipila et al., 2009; Nardou et al.,
2011) Importantly, KCC2 has recently been shown to be necessary for GABAAR mediated
excitation in the SCN (Olde Engberink et al., 2018) (Figure 1.8).
1.13.3 NKCC1 overview
Na+/K+/Cl- cotransporter 1 (NKCC1) is the CCC largely responsible for controlling
chloride ion influx in neurons (Figure 1.8). NKCC1 is widespread and expressed throughout
most of the brain (Delpire et al., 1994; Payne et al., 1995). Slc12a2 (solute carrier family 12
member 2, the gene that encodes NKCC1 mRNA, is also found in the adult rodent PNS and in
glial cells (Hubner et al., 2001; Price et al., 2006).
As mentioned, NKCC1 also plays a role in the predominantly excitatory GABAAR
responses early in development. Evidence suggests that NKCC1 is globally down regulated
during development in rodent and human brains and is thought to be a part of the mechanism in
GABA changing from predominantly excitatory to predominantly inhibitory (Plotkin et al.,
1997; Dzhala et al., 2005; Aronica et al., 2007). However, other work suggests the opposite
change in NKCC1, an up-regulation during development of NKCC1 mRNA in the CNS of both
rodents and humans (Morita et al., 2014). It is possible these differences occur due to the studies
involving different brain regions. It is also possible that these discrepancies are due to the use of
probes and antibodies that target different splice variants or protein products of Slc12a2 (Randall
et al., 1997; Clayton et al., 1998; Vibat et al., 2001; Morita et al., 2014; Puskarjov et al.,
2014a; Puskarjov et al., 2014b). These differences will be addressed in Chapter 3. Overall,
Nkcc1b shows higher expression the adult human brain (Kaila et al., 2014).
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1.13.4 Regulation of CCC activity
The CCC capacity for transport of chloride is determined by the number of functional
transporters in membrane as well as the rates of ion turnover and ion translocation (Balakrishnan
et al., 2003;

Blaesse et al., 2006;

Zhang et al., 2006;

Khirug et al., 2010). Membrane

trafficking, activation and deactivation by phosphorylation and dephosphorylation, and
proteolytic cleavage regulate the number of functional transporters. Lysine deficient protein
kinase 1 (WNK1), acting via STE20-type kinases (SPAK and OSR1), sense chloride and alter
phosphorylation states of chloride cotransporters based on intracellular chloride concentrations
(Delpire and Gagnon, 2008; Alessi et al., 2014; de Los Heros et al., 2014; Piala et al., 2014).
WNK, via SPAK and OSR1, bind and phosphorylate NKCC1 and activate the influx of chloride
whereas SPAK and OSR1 phosphorylation of KCC2 decreases its chloride efflux actions (de los
Heros 2014, Rinehart 2009, Inoue 2012) (Rinehart et al., 2009; Inoue et al., 2012; de Los Heros
et al., 2014). Thus, the same kinase pathway regulates Cl- influx and efflux proteins with
opposite effects on CCC activity. If [Cl-i] falls, NKCC1 is phosphorylated at its N-terminal
residue and, in this way, becomes active and begins to restore [Cl-i] (Haas et al., 1995; Lytle and
Forbush, 1996). In turn, when [Cl-i] increases, KCC2 becomes active via dephosphorylation and
begins to efflux chloride, allowing these CCCs to reciprocally regulate [Cl-i] (Williams and
Payne, 2004). In pathological states associated with hyper-excitability, such as neonatal seizures
and spinal cord injury, an up-regulation of KCC2-mediated chloride extrusion leads to GABAAR
hyperpolarizing responses, hypothesized to be a protective mechanism that may rescue the
hyper-excited neuronal populations from excitotoxicity (Khirug et al., 2010;
2013)(See Chapter 4 for clinical considerations).

Bos et al.,

44

1.13.5 CCC control of inhibitory signaling in the brain
There are two main types of GABAAR activity-dependent inhibition. Shunting inhibition
is a short-circuit-like process that suppresses both temporal and spatial summations of the
depolarizing effect of EPSCs and intrinsic excitatory currents (Sjostrom et al., 2008; Gidon and
Segev, 2012). Another, more classic type of GABAAR inhibition, is voltage inhibition that is
induced by hyperpolarizing IPSPs. This voltage inhibition, enabled by lower intracellular than
extracellular chloride concentrations, due to coordinated NKCC1-mediated chloride influx and
KCC2-regulated chloride efflux, attenuates as it moves along the plasma membrane as allowed
by the specific membrane time and space constants (Jack, 1975; Farrant and Kaila, 2007).
It is important to note that GABAAR channels are not selective for chloride alone.
GABAARs and GlyRs carry chloride and bicarbonate ion (HCO3-) currents with a HCO3- /Clratio of .2 to .4 (Fatima-Shad and Barry, 1993; Farrant and Kaila, 2007). If KCC2 is active and
creates low [Cl-i], ECl- is more negative than Vrest and the driving force can be hyperpolarizing or
depolarizing (Kaila et al., 1993; Sun et al., 2012a). Thus, depolarization at GABAergic synapses
can be excitatory and these responses are often referred to as GABA PSPs. These responses are
often observed in immature or diseased neurons, but also in adult neurons with high NKCC1mediated chloride influx (Chen et al., 1996; van den Pol et al., 1996; Kohling et al., 1998; Kilb
et al., 2008; Kim et al., 2013; Loscher et al., 2013).
1.13.6 Summary of CCCs and GABAAR-mediated inhibition and excitation
GABA is certainly the primary inhibitory neurotransmitter in the mature brain. However,
studies over the last few decades suggest that GABA can also act as an excitatory
neurotransmitter outside of this early life window. Typically, GABA is inhibitory when
intracellular chloride concentrations are lower than extracellular chloride concentrations
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resulting in an influx of chloride ions through the GABAAR ion pore, hyperpolarizing the cell.
Thus, GABA can excite neurons when this ‘typical’ intracellular/extracellular chloride ion
distribution is reversed, resulting in outward current (efflux of Cl- ions) and depolarization of the
cell (Figure 1.8). GABA has been reported to have excitatory effects in the adult brain in many
brain regions studied to date, such as the SCN, amygdala, hippocampus, and cortex (Haam et al.,
2012).
It is becoming increasingly apparent that CCCs are a major contributor to the
maintenance of the chloride gradient involved in postsynaptic inhibition through GABAARs. At
present, there is substantially more information about the function of NKCC1, KCC2, and KCC3
than the other CCC isoforms in regulating chloride gradients and therefore the polarity of
GABAAR activity in the brain (Benarroch, 2013; Kaila et al., 2014).
1.14 CCCs and the SCN
1.14.1 Developmental GABAAR responses in the SCN
The developmental transition from predominantly GABA excitation to predominantly
inhibition is also likely the case in SCN tissue as GABA primarily elevates intracellular Ca2+
until postnatal day (PD) 10 at which point GABA begins to reduce intracellular Ca2+ in most
SCN neurons (Obrietan and van den Pol, 1995; Ikeda et al., 2003). Another study, in which
dissociated SCN cells from PD4 rats were recorded from PD4-109, suggests that GABA inhibits
the firing of a majority of SCN neurons. However, direct GABA application excited 20-40% of
the neurons (Shirakawa et al., 2000).
1.14.2 CCC expression in the SCN
Detailed anatomical studies reveal that NKCC1s and KCCs are expressed throughout the
SCN (Kanaka et al., 2001; Belenky et al., 2008; Belenky et al., 2010). KCC2 is colocalized
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with VIP and GRP neurons within the vSCN and is often closely associated with neurons
receiving RHT and GHT input. In contrast, KCC2 is not expressed in the dSCN, thus not
colocalized with AVP neurons, though this has only been explored in rats. Similarly, KCC1 is
also found in the vSCN and much less so in the dSCN. KCC4, on the other hand, is colocalized
with AVP in neurons of the dSCN and is typically found on somata and dendrites but not on
axons. KCC3, like KCC4, is found in AVP neurons and is found primarily in cell bodies
(Belenky et al., 2010). The relative roles of KCC1-4 in the removal of chloride from within SCN
neurons are unknown; however, there is evidence that KCC2 has higher cation affinity than
KCC1, 3, or 4 and recent findings suggest that blocking KCC2 increases excitatory GABA
responses in the SCN (Mercado et al., 2006; Olde Engberink et al., 2018). NKCC1 can be found
in AVP, VIP and GRP containing neurons of the SCN though no work, to our knowledge, has
described if these cotransporters are found in the important calbindin region of the Syrian
hamster SCN (Belenky et al., 2010) (Figure 1.9). In rats, GABA excitation of SCN neurons has
been reported to be less prevalent at night than during the day (Wagner et al., 2001). In mice,
however, NKCC1 protein and the likelihood of GABA-evoked excitation is elevated in the night
and in the dSCN (Choi et al., 2008). Needless to say, there is far from a consensus on the phase
and location of these excitatory responses to GABA in the SCN that may center around
differences in species, recording techniques, or yet other experimental design differences (for a
review see: (Albers et al., 2017). Given the importance of ion gradient maintenance as a core
principal in driving forces controlling electrical signaling in the CNS, CCCs likely play an
important role in determining the electrical activity of SCN neurons. These cotransporters do this
by establishing Cl- gradients, which in turn determine the polarity of the response upon GABA
binding its GABAAR. Because CCCs play a critical role in determining the polarity of the
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response to GABA, understanding their functions in the SCN will become increasingly important
as the potential circadian functions of the ratio of GABA excitation: inhibition are more clearly
defined.

Figure 1-9: NKCC1 in the SCN
Photomicrograph of NKCC1 protein fluorescence in the SCN. NKCC1 protein is
expressed throughout the vSCN and dSCN (McNeill et al., 2018, in preparation).
1.14.3 Excitatory effects of GABA on SCN neurons
Most data indicate that application of GABA to the adult SCN in vitro produces primarily
inhibitory responses during the day and night. In fact, some report GABA to produce almost
exclusively inhibitory effects within the SCN (Mason et al., 1991). A number of other studies,
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however, report that GABA excites some SCN neurons in a phase-dependent fashion, though the
time of day this occurs is still debated (Liou and Albers, 1990; Liou et al., 1990; Wagner et al.,
1997; De Jeu and Pennartz, 2002; Choi et al., 2008; Freeman et al., 2013). In some reports
GABA first produces an increase in firing followed by a decrease in firing in some SCN neurons
(Shibata et al., 1983; Choi et al., 2008).
Like the reported effects of GABA, the GABAAR agonist muscimol can lead to inhibition
or excitation followed by inhibition in the hypothalamic slice preparation and dispersed cell
culture (Liou et al., 1990; Tominaga et al., 1994; Liu and Reppert, 2000). Muscimol has rarely
been found to be exclusively excitatory, though it is important to note that muscimol is a
promiscuous GABAAR agonist acting on GABAARs with many different subunit compositions
(see section on GABAARs). The GABAAR antagonist bicuculline should induce excitatory
responses in neurons where GABA induces inhibition and inhibitory responses in neurons where
GABA induces excitation (Wagner et al., 1997). Some reports suggest that bicuculline produces
only excitatory responses (Mason et al., 1991; Gribkoff et al., 1999; Gribkoff et al., 2003).
However, in other studies, bicuculline produces both excitation and inhibition (Liou et al., 1990;
De Jeu and Pennartz, 2002; Albus et al., 2005). These cellular effects of bicuculline are also
phase dependent (De Jeu and Pennartz, 2002).
1.14.4 GABA effects in the SCN: day vs. night and dorsal vs. ventral
As mentioned, there appears to be a lack of consensus about the time of day GABA has
inhibitory and/or excitatory effects on the SCN, although most, but not all, reports agree GABA
has different effects on SCN neurons at different times during the light dark cycle or during
different phases of the circadian cycle. Some studies report no differences in the effects of
GABA administered during the subjective day versus the subjective night (Liou and Albers,
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1990; Mason et al., 1991; Gribkoff et al., 1999; Gribkoff et al., 2003). Other studies show
GABA to be excitatory during the day in a substantial number of SCN neurons (Wagner et al.,
1997; Wagner et al., 2001). However, still others report that GABA is more likely excitatory
during certain parts of the subjective night (De Jeu and Pennartz, 2002; Choi et al., 2008; Irwin
and Allen, 2009). There also seems to be a discrepancy in the literature as to the dorsal/ventral
response to GABA. Some studies have found that GABA has similar effects throughout the SCN
(Shibata et al., 1983). The most comprehensive study on the effects of GABA on SCN neuronal
firing of 786 SCN neurons, shows GABA produces excitation in a substantial proportion of
neurons in both the dSCN and vSCN. This same report also shows that the excitatory effects of
GABA were most common in the dSCN at night (Choi et al., 2008). Importantly, in all studies of
GABA-evoked excitation in the SCN, bumetanide, a potent inhibitor of NKCC1, abolished these
excitatory responses. It is apparent that additional studies are necessary to reach a consensus
about both the cellular responses and functional significance of GABA-induced excitation in the
SCN.
1.15 GABA equilibrium potential in the SCN
The spatial and temporal patterns of the chloride driven GABA equilibrium potential in
SCN neurons have been examined using both perforated patch clamp and whole patch clamp
experiments (Alamilla et al., 2014). The patch clamp experiments show two main populations of
SCN neurons in terms of their responses to GABA. 50% of the recorded neurons have an
equilibrium potential of GABA postsynaptic currents (EGABA) that are hyperpolarized, as is
typically observed in GABAergic neurons, and are, therefore, inhibitory. The other half of SCN
neurons display an EGABA that is depolarized, leading to an outward flux of chloride ions and an
excitatory response following GABAAR activation. In contrast with Choi et al (2008) this same
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study shows that in the dSCN, more neurons have a more “excitatory” EGABA during the day as
compared with the night; while in the vSCN fewer neurons have an “excitatory” EGABA during
the day as compared with the night (Alamilla et al., 2014). However, another report that
quantifies chloride concentrations suggests that the chloride equilibrium potentials are higher in
the dSCN than in the vSCN, with no observed differences in chloride levels in the day versus the
night (DeWoskin et al., 2015).
1.16 Intracellular Ca2+ concentration [Ca2+i] response to GABA in the SCN
Other labs have studied the cellular effects of GABA in the adult SCN by exploring how
GABA influences intracellular Ca2+ concentrations using Ca2+ imaging techniques (Choi et al.,
2008; Irwin and Allen, 2009). In general, GABA-induced increases in intracellular Ca2+ are
associated with membrane depolarization (excitation) while GABA-induced decreases in Ca2+
are associated with hyperpolarization (inhibition). Applying GABA to the hypothalamic slice
preparation increases Ca2+ in some SCN neurons (Ca+), decreases Ca2+ in other SCN neurons
(Ca-), and has no effect on Ca2+ levels in still other SCN neurons (Ca0). Using this technique,
Irwin and Allen (2009) found significantly more Ca+ neurons and fewer Ca- neurons in the SCN
at night than during the day. Furthermore, a higher proportion of “Ca+” neurons were identified
in the dSCN than in the vSCN. In addition, more neurons either showed a decrease or no change
in intracellular calcium to GABA treatment in the vSCN than in the dSCN (Irwin and Allen,
2009). These observed calcium responses were similar with RHT stimulation and GABA
application to SCN neurons. The GABAAR agonist muscimol increases intracellular Ca2+ in
some SCN neurons and reduces intracellular Ca2+ in others (Irwin and Allen, 2009).
Interestingly, administration of the GABAAR antagonist gabazine eliminates GABA-induced
Ca2+ increases but does not eliminate the ability of GABA to reduce Ca2+ in all cases. Thus, it is
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possible that GABA acts on subtypes of GABA receptors at which gabazine was ineffective. As
expected, when using a GABAAR antagonist, most SCN neurons in which GABA affects
intracellular Ca2+ levels, gabazine has the opposite effect. In contrast, activation of GABABRs,
using the GABABR agonist baclofen, consistently reduces intracellular Ca2+ levels in SCN
neurons. This finding suggests that the activation of GABAB receptors consistently results in
inhibition (Irwin and Allen, 2009).
1.17 Photoperiodic responsiveness of NKCC1 in the SCN
In addition to circadian changes in the excitation: inhibition ratio of SCN neurons to
GABA application, a recent study in mice shows that the length of the photoperiod in prior
entrainment can alter the percentage of excitatory and inhibitory responses to GABA in the SCN
(Farajnia et al., 2014; Myung et al., 2015b). When the mouse is entrained to a LD 16:8, 40% of
SCN neurons display excitatory Ca+2 transients in response to GABA while 32% are inhibitory.
In contrast, when previously entrained to an LD 8:16, 28% of SCN neurons display excitatory
Ca+2 transients in response to GABA and 52% are inhibitory. If previously entrained to an
equinoctial LD 12:12, the ratio of excitation: inhibition in response to GABA is intermediate to
the long and short day responses. In these studies, the excitatory effects of GABA did not differ
across subregions of the SCN, unlike the aforementioned reports of sub-regional differences in
GABA-induced excitation/inhibition (see above). These photoperiodic effects on GABA
excitation:inhibition are also blocked by the NKCC1 inhibitor bumetanide. These dramatic
photoperiod-induced changes in the excitatory versus inhibitory effects of GABA within the
SCN have led to the hypothesis that this ratio may be involved in encoding seasonal changes in
photoperiod length (Farajnia et al., 2014; Myung et al., 2015b). Interestingly, prior entrainment
to short photoperiods (e.g., 10 hrs. of light per day) leads to a broader phase response curve to
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light and enhances the magnitude of both delays and advances when compared to animals housed
in longer photoperiods (e.g., 14 or 18 hours of light per day (Pittendrigh, 1984; Evans et al.,
2004). These ideas will be discussed in Chapter 3.
1.18 Summary of aims
GABA is most commonly viewed as the primary inhibitory neurotransmitter in the CNS,
but in vitro studies suggest the presence of excitatory GABA responses in the adult SCN, though,
to our knowledge, no in vivo studies exist. The actions of cation chloride cotransporters (CCC)
are critical in determining whether GABA is hyperpolarizing or depolarizing in the immature
and mature brain. Importantly, excitatory GABA responses in the adult SCN disappear upon
inhibition of the inward chloride co-transporter, Na+/K+/Cl- co-transporter 1 (NKCC1). Thus,
the overarching hypothesis of the work contained herein, is that excitatory SCN GABAAR
responses regulate phase changes of the circadian clock. We tested this hypothesis with three
specific aims to follow:
Specific Aim 1: Test the hypothesis that excitatory responses to GABAAR binding are
necessary for the SCN to shift in response to photic stimuli.
Specific Aim 2: Test the hypothesis that excitatory GABA responses in the SCN are
necessary for the SCN to shift to non-photic stimuli.
Specific Aim 3: Test the hypothesis that light duration enhances NKCC1 expression and
NKCC1 displays a circadian and/or daily rhythm in the Syrian hamster SCN.
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2

FUNCTIONAL SIGNIFICANCE OF THE EXCITATORY EFFECTS OF GABA IN
THE SUPRACHIASMATIC NUCLEUS

2.1

Abstract
Over 90% of neurons within the suprachiasmatic nucleus (SCN) express γ-aminobutyric

acid (GABA). Although GABA is primarily an inhibitory neurotransmitter, in vitro studies
suggest the activation of GABAA receptors elicits excitation in the adult SCN. The ratio of
excitatory to inhibitory responses to GABA depends on the balance of chloride influx by
Na+/K+/Cl- co-transporter 1 (NKCC1) and chloride efflux by K+/Cl- co-transporters (KCCs).
Excitatory responses to GABA can be blocked by inhibition of the inward chloride cotransporter, Na+/K+/Cl- co-transporter 1 (NKCC1), with the loop diuretic bumetanide. Here we
investigated the role of NKCC1 activity in phase shifting the circadian pacemaker in response to
photic and non-photic signals in male Syrian hamsters housed in constant darkness. In the early
subjective night (CT 13.5), injection of bumetanide into the SCN reduced light-induced phase
delays. However, during the late subjective night (CT 19), bumetanide administration did not
alter light-induced phase advances. Injection of bumetanide during the subjective day (CT 6) did
not alter the phase of free-running circadian rhythms but attenuated phase advances induced by
injection of the GABAAR agonist muscimol into the SCN. These data support the hypothesis that
the excitatory effects of endogenously released GABA contribute to the ability of light to induce
phase delays; thereby contributing to the most important function of the circadian system, its
entrainment with the day-night cycle. Further, the finding that bumetanide inhibits the phase
advancing effects of muscimol during the subjective day supports the hypothesis that the
excitatory responses to GABA also contribute to the ability of non-photic stimuli to phase shift
the circadian pacemaker.
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2.2

Introduction
The suprachiasmatic nuclei (SCN) play a key role in the circadian control of physiology

and behavior in mammals, including humans (Moore and Eichler, 1972; Stephan and Zucker,
1972; Cohen and Albers, 1991). Two of the most important functions of the SCN are generating
self-sustained oscillations and adjusting the period of those oscillations with the 24-hour daynight cycle through the process of entrainment (Daan and Pittendrigh, 1976; Johnson et al.,
2003). Light in the early subjective night phase delays the pacemaker; light in the late subjective
night phase advances the pacemaker; while light in the subjective day does little to shift the clock
(Decoursey, 1960;

Daan and Pittendrigh, 1976). Light is transduced in specialized retinal

ganglion cells and communicated to the SCN via the release of glutamate from terminals of the
retinohypothalamic tract (RHT) (Hendrickson et al., 1972; Moore and Lenn, 1972; Pickard,
1982; Colwell et al., 1991; Mintz et al., 1999; Berson et al., 2002; Sollars et al., 2003).
Although the RHT appears to be the major light input pathway regulating many of the
effects of the strongest zeitgeber on the SCN, other stimuli can also induce phase shifts of the
pacemaker. Non-photic phase shifting stimuli include the injection of neuropeptide Y-like
peptides, discrete bouts of resident-intruder interactions, or exposure to a novel running wheel
(Albers and Ferris, 1984;

Mistlberger, 1991;

Biello and Mrosovsky, 1995;

Biello and

Mrosovsky, 1996; Mistlberger et al., 2003). In nocturnal rodents, non-photic stimuli produce a
pattern of phase shifts, i.e., small phase delays during subjective night and large phase advances
during subjective day, that differ greatly from those produced by light. Stimuli that induce nonphotic phase shifts are relayed to the SCN via projections from other brain regions including a
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direct projection from the intergeniculate leaflet and a serotonin-containing projection from the
raphe (Swanson et al., 1974; Ribak and Peters, 1975; Meyer-Bernstein and Morin, 1996;
Morin, 1999; Morin, 2013). Finally, the SCN provide output signals that serve to entrain
physiological systems throughout the body with the day-night cycle (Kalsbeek et al., 2006;
Morin, 2013).
The SCN is a network of γ-aminobutyric acid (GABA)-containing cells. GABA synthesis
and transporter proteins as well as GABA receptors are expressed in more than 90% of SCN
neurons (van den Pol and Tsujimoto, 1985; van den Pol and Gorcs, 1986; Okamura et al., 1989;
Moore and Speh, 1993; O'Hara et al., 1995; Castel and Morris, 2000a; Albers et al., 2017).
Two major classes of GABA receptors, GABAA and GABAB receptors, mediate the effects of
GABA within the SCN. GABAA receptors are ligand-gated chloride ion channels whose subunit
composition determines their pharmacological properties, subcellular localization, and rhythmic
regulation within the SCN (Farrant and Nusser, 2005; Walton et al., 2017). GABAB receptors
are metabotropic G-protein-coupled receptors that can be found on presynaptic, postsynaptic,
and extrasynaptic membranes (Enna and McCarson, 2013). GABA can modulate the ability of
the pacemaker to phase shift in response to light by acting on GABAA and GABAB receptors
(Ralph and Menaker, 1985; Ralph and Menaker, 1986; Ralph and Menaker, 1989; Gribkoff et
al., 1998; Mintz et al., 2002a; Albers et al., 2017). The GABAAR agonist muscimol and the
GABABR agonist baclofen administered into the SCN inhibit phase delays in response to light in
the early subjective night and decrease light-induced phase advances in the late subjective night
(Gillespie et al., 1997; Gillespie et al., 1999; Novak and Albers, 2004a). In addition, GABAAR
and GABABR antagonists administered in the SCN enhance phase delays to light in the early
subjective night (Gillespie et al., 1996). GABAARs also play a critical role in mediating the
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sustained effects of light on SCN firing rates and gene expression. The sustained activation of
GABAARs (> 4 hrs.) is both necessary and sufficient to regulate the phase delaying effects of
light in the early subjective night (Hummer et al., 2015).
GABAAR signaling is also critical in SCN processing of non-photic phase shifting stimuli
(Webb et al., 2014). For example, bicuculline blocks neuropeptide Y (NPY) induced phase
advances when given in the SCN during the middle of the subjective day (Huhman et al., 1995;
Huhman et al., 1997; Gribkoff et al., 1998). Interestingly, muscimol and diazepam, both drugs
that act on GABAARs, phase advance the pacemaker when administered during the subjective
day in nocturnal rodents but induce phase delays in the day-active grass rat (Smith et al., 1989;
Mintz et al., 2002a; Novak and Albers, 2004a; McElroy et al., 2009). Thus, activation of
GABAARs plays a key role in regulating SCN mechanisms mediating the phase shifting effects
of both photic and non-photic stimuli.
Although GABA is most commonly viewed as the primary inhibitory neurotransmitter in
the adult brain, it is now clear that it can also have excitatory effects. The actions of cation
chloride cotransporters (CCCs) are critical in determining whether GABA is hyperpolarizing or
depolarizing (Xu et al., 1994; Gillen et al., 1996; Payne et al., 1996; Markadieu and Delpire,
2014). Two main types of CCCs regulate intracellular chloride. Na-K-2Cl cotransporters
(NKCCs) transport chloride ions (stoichiometry 1Na+: 1K+: 2Cl-) into cells (in two identified
isoforms), NKCC1 and NKCC2. K-Cl cotransporters (KCCs) extrude chloride ions from the cell
(stoichiometry 1K+: 1Cl-), with four identified isoforms (KCC1-4). Thus, as the GABAA receptor
opens a chloride pore when active, the probability of depolarizing a GABAA receptor expressing
neuron is determined by the ratio of the activity of chloride influx (NKCC1) to chloride efflux
(KCCs) (For review: (Markadieu and Delpire, 2014).
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The cellular responses to GABA within the SCN have been extensively studied using a
variety of approaches and yet there is little consensus on when, where, and if GABA produces
excitatory responses in SCN neurons (Wagner et al., 1997; Liu and Reppert, 2000; De Jeu and
Pennartz, 2002; Itri et al., 2004; Albus et al., 2005; Aton et al., 2006; Choi et al., 2008; Irwin
and Allen, 2009; Myung et al., 2012; Freeman et al., 2013; Farajnia et al., 2014; Albers et al.,
2017). While there is agreement that GABA has substantial inhibitory effects in the SCN, some
studies report that GABA is exclusively inhibitory, others that GABA can be excitatory during
the day, and still others that GABA can be excitatory during the night. There is also controversy
on whether the excitatory effects of GABA are more frequently observed in different subregions
of the SCN. Importantly, NKCC1 is found in SCN neurons of the dorsal (dSCN) and ventral
(vSCN) nuclei, regardless of time of day, and electrophysiologically recorded excitatory
responses to GABA in the adult SCN disappear upon pharmacological inhibition of NKCC1 with
bumetanide (Choi et al., 2008; Irwin and Allen, 2009; Belenky et al., 2010). Perhaps the most
parsimonious view of this complex body of evidence may be that GABA is primarily inhibitory
during the day but that it has excitatory effects on a substantial number of SCN neurons at night
(see Albers et al., 2017 for a review). Nevertheless, a significant number of GABA-excitable
SCN neurons have been identified during the day (Liou and Albers, 1990; Wagner et al., 1997;
Choi et al., 2008; Irwin and Allen, 2009; Alamilla et al., 2014).
Despite the important role of GABAAR signaling in phase shifting responses to both
photic and non-photic stimuli, the role of these CCCs in phase shifting the pacemaker is not
known. Considering the prevalence of GABAAR signaling in SCN neurons, the role of GABAAR
signaling in regulating the phase of the pacemaker, and the significant percentage of SCN
neurons depolarized by GABA, it seems likely that excitatory responses to GABA play a
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functional role in entrainment within the intact SCN. The aim of these experiments was to test
the hypothesis that NKCC1 activity within the SCN regulates both photic and non-photic phase
shifting in the fully intact circadian system.
2.3
2.3.1

Materials and methods
Animals, light treatment, and activity monitoring
Adult male Syrian hamsters (approximately 9-10 weeks; 120-140g) were purchased from

Charles River Labs and individually housed in polycarbonate cages. All hamsters were held in a
14:10 light: dark (LD) cycle for 7-10 days (25° ± 1° C) and allowed to acclimate to the animal
facility and the LD cycle. Food (Lab Diet-#5001) and water were provided ad libitum. After the
acclimation period, a single unilateral cannula was implanted aimed at the SCN in each hamster
and hamsters were allowed to recover from surgery (≈days 8-15; LD 14:10). Next, hamsters
were transferred to constant darkness (DD) for 10-14 days allowing for the establishment of freerunning activity rhythms. All hamsters were held for a total of 15-20 days in LD 14:10 before
release into constant conditions. The light stimulus used to induce phase delays and advances
(CT 13.5 and CT 19, respectively) was a 150-lux 15-min light pulse (LP). Animal facility staff
used a Kodak LED Safelight (660 nm) for routine animal husbandry. Each cage was equipped
with a running wheel and locomotor activity was monitored as wheel revolutions/10 minutes and
collected with VitalView Software (Mini Mitter, Bend, OR, USA). All procedures conformed to
National Institutes of Health guidelines and were approved by the Institutional Animal Care and
Use Committee of Georgia State University.
2.3.2

Surgery and drug administration
Hamsters were deeply anesthetized (5% isoflurane induction; 2.5-3.5% isoflurane for

maintenance), placed into a stereotaxic device, and implanted with 4 mm, 26-gauge guide
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cannulae (PlasticsOne, Roanoke, VA) aimed at the SCN (0.80 mm anterior; 1.7 mm lateral to
bregma, 10° angle toward midline). Microinjections were administered via a 33-gauge needle
attached to polyethylene tubing (PE-20) and connected to a 1.0 µl Hamilton syringe.
Microinjection volumes were 200 nanoliters and were administered over twenty seconds. The
injection needle was left in place for 30 seconds after injection to allow for diffusion of the
solution. The depth of microinjection was 7.2 mm ventral to bregma. Injections and light pulses
were given after approximately 10-14 days of exposure to DD. Bumetanide, dissolved in
dimethyl sulfoxide (DMSO) as vehicle (Sigma Aldrich, St. Louis, MO), was used to inhibit
NKCC1 chloride influx in order to decrease GABA elicited excitatory responses in the SCN
(Payne et al., 2003; Choi et al., 2008; Irwin and Allen, 2009). The solubility of bumetanide has
been reported to range from 25 mM to > 200 mM based on information from several different
manufacturers and chemical societies. For the present study we were able to dissolve up to 1 M
bumetanide in fresh (important due to the hygroscopicity of DMSO) 100% DMSO. Multiple
doses, beginning with a low dose of 10 µM, were used to generate dose-responses to bumetanide
injected into the SCN region in vivo. Upon completion of each experiment, injection sites were
verified with dye injection, histological preparation, and light microscopy. Unilateral injections
of 200 nL spread slightly less than 1 mm from the injection site and, thus, diffuse to the
contralateral SCN (Gillespie et al., 1999; Caldwell and Albers, 2003; Paul et al., 2005; Albers
et al., 2017). Further, injections of GABA active drugs 500 µm or more from the SCN do not
induce phase shifts in activity rhythms (Hummer et al., 2015). The adult Syrian hamster SCN is
around 0.6 mm x 0.3 mm x 0.6 mm (in the rostrocaudal, mediolateral, and dorsoventral axes,
respectively) (Lydic et al., 1982). Thus injection sites further than 500 µm from the border of the
SCN as well as sites showing SCN damage were excluded from further analysis.
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2.3.3

Early and late subjective night
To investigate the role of NKCC1 activity in light-induced phase delays at CT 13.5 and

light-induced phase advances at CT 19, hamsters were microinjected with bumetanide (10 µM,
100 µM, or 1 mM) or vehicle into the SCN region immediately followed by a 15-minute 150-lux
light pulse (LP) or a sham-LP (hamster removed from cage under safe light for drug injection)
(Table 1). After treatment, hamsters were immediately returned to their home cages in DD and
wheel running was continually monitored for 10-14 more days.
2.3.4

Subjective day
As muscimol injection into the SCN during the subjective day (CT 6) induces phase

advances in activity rhythms, (Smith et al., 1989; Huhman et al., 1995; Gribkoff et al., 1998;
Mintz et al., 2002a) we explored the role of NKCC1-mediated excitation of SCN neurons in
these GABAAR-signaled phase advances in hamsters housed in DD. This treatment mimics the
phase advances induced by several non-photic stimuli (Mrosovsky et al., 1992; Mrosovsky,
1996). At CT 6, hamsters were microinjected with bumetanide alone (10 µM, 100 µM, or 1 mM),
vehicle, or the same concentrations of bumetanide in a cocktail with a phase advancing dose of
muscimol (21.9 mM) (Mintz et al., 2002a) (Table 1). After injection, animals were returned to
their home cages in DD and wheel running was continually monitored for 10-14 more days.
2.3.5

Statistical analysis
Phase shifts were quantified using the linear regression method (Daan and Pittendrigh,

1976). Regression lines were fit to activity onsets for 7-10 days, both for pre-test baselines and
post-manipulation onsets (ClockLab; Actimetrics, USA). Post-injection regression lines omitted
2-3 days of onsets following injection due to transient effects of light and handling on the freerunning rhythm. Data are represented with mean (±SEM) phase shifts (hrs.) and were analyzed

63

using one-way ANOVA followed by a Tukey’s HSD post hoc test for significant ANOVAs.
Significance was set at p ≤ 0.050.
2.4
2.4.1

Results
Effect of inhibition of NKCC1 on light-induced phase delays (CT 13.5)
Injection of bumetanide, an inhibitor of NKCC1, into the SCN region prior to a light

pulse at CT 13.5 decreased the magnitude of light-induced phase delays (F(3,23) = 3.135,
p=0.045). Tukey’s HSD post hoc testing revealed that 10 µM bumetanide decreased the
magnitude of the phase delay when compared with vehicle (p=0.027). The other two
concentrations (100 µM and 1 mM) of bumetanide did not differ from vehicle or 10 µM
bumetanide (Fig. 2.1). Injection of bumetanide alone (without light) at CT 13.5 did not produce
phase shifts when compared with vehicle controls (F(3,12) = 0.168, p=0.916) (Fig. 2.2).
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Figure 2-1: NKCC1 inhibition and phase delays to light
Effects of the NKCC1 inhibitor bumetanide injected into the SCN on light-induced phase
delays of the circadian locomotor rhythm in the early subjective night (CT 13.5). Top: 10 µM
bumetanide reduced phase delays in response to light at CT 13.5 as compared with vehicle (*p ≤
0.05). Middle and Bottom: Representative wheel-running actograms for vehicle injection +
light pulse and 10 µM bumetanide injection + light pulse, respectively. Gray boxes denote
manipulation time point (i.e., drug treatment + light pulse).
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Figure 2-2: NKCC1 inhibition in the early subjective night
Effects of the NKCC1 inhibitor bumetanide injected into the SCN on the phase of the
circadian locomotor rhythm in the early subjective night (CT 13.5). Top: Bumetanide did not
produce phase shifts in the free-running locomotor rhythm at any concentration (p > 0.05).
Middle and Bottom: Representative wheel-running actograms for vehicle injection and 10 µM
bumetanide injection, respectively. Gray boxes denote manipulation time point (i.e., drug
treatment).

2.4.2

Effect of inhibition of NKCC1 in the late subjective night (CT 19)
During the late subjective night (CT 19), injection of bumetanide into the SCN region did

not alter the magnitude of light-induced phase advances (F(3,23) = 0.445, p=0.723) (Fig. 2.3).
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Analysis of variance of bumetanide injected into the SCN region in the late subjective night (CT
19) in the absence of light produced a significant F statistic (F(3,25) = 3.092, p=0.045).
However, Tukey’s HSD post hoc analysis found significant effect of any concentration. The 10
µM concentration of bumetanide trended towards a small advance of activity onset when
compared with other treatments (p=0.054 to .091) (Fig. 2.4).

Figure 2-3: NKCC1 inhibition and phase advances to light
Effects of the NKCC1 inhibitor bumetanide injected into the SCN on light-induced phase
advances of the circadian locomotor rhythm in the late subjective night (CT 19). Top:
Bumetanide did not alter the magnitude of light-induced phase advances at any concentration (p
> 0.05).
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Figure 2-4: NKCC1 inhibition in the late subjective night
Effects of the NKCC1 inhibitor bumetanide injected into the SCN in the late subjective
night (CT 19) on the phase of the circadian locomotor rhythm. Top: Bumetanide injection into
the SCN did not phase shift the circadian locomotor rhythm in the late subjective night (CT 19)
(p > 0.05).

2.4.3

Effect of inhibition of NKCC1 during the subjective day (CT 6)
Next, we explored if NKCC1 inhibition in the subjective day phase shifts the free-

running activity rhythm. Injection of bumetanide alone into the SCN at CT 6 did not produce
significant phase shifts at any concentration (F(3,19) = 3.080, p=0.052)(Fig. 2.5). We also
examined whether NKCC1 activity modulates the phase advances produced by injection of the
GABAAR agonist muscimol during the subjective day. We co-administered the same 3
concentrations of bumetanide used at CT 13.5 and CT 19 in a cocktail with a concentration of
muscimol previously shown to produce phase advances during the subjective day (21.9
mM)(Mintz et al., 2002a). Analysis of variance revealed a main effect of drug treatment (F(4,27)
= 4.152, p=0.010). Tukey’s HSD post hoc testing revealed that muscimol (21.9 mM)
administration led to a significant phase advance of the rhythm compared with controls
(p=0.010) (Fig. 2.6). A bumetanide concentration of 100 µM attenuated muscimol-induced phase
advances (p=0.024). Lower and higher concentrations of the NKCC1 inhibitor did not differ
from muscimol administered alone (Fig. 2.6).
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Figure 2-5: NKCC1 inhibition in the subjective day
Effects of the NKCC1 inhibitor bumetanide injected into the SCN on the phase of the
circadian locomotor rhythm during the subjective day (CT 6). Top: Bumetanide did not produce
phase shifts in the free-running locomotor rhythm at any concentration (p > 0.05). Middle and
Bottom: Representative wheel-running actograms for vehicle injection and 100 µM bumetanide
injection, respectively. Gray boxes denote manipulation time point (i.e., drug treatment).
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Figure 2-6: NKCC1 inhibition and muscimol-induced phase advances
Effects of the NKCC1 inhibitor bumetanide injected into the SCN on muscimol-induced
phase advances of the circadian locomotor rhythm during the subjective day (CT 6). Top:
Muscimol administration into the SCN phase advanced the circadian locomotor rhythm
compared with vehicle control (*p ≤ 0.05). Muscimol-induced phase advances were reduced by
injection of 100 µM bumetanide (*p ≤ 0.05). Middle and Bottom: Representative wheel-running
actograms for 21.9 mM muscimol injection and 100 µM bumetanide + 21.9 muscimol injection,
respectively. Gray boxes denote manipulation time point (i.e., drug treatment).
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2.5

Discussion
These data indicate that injection of the NKCC1 inhibitor bumetanide within the SCN

modulates the ability of the pacemaker to phase shift in response to both photic and non-photic
stimuli. In the early subjective night (i.e., CT 13.5), injection of bumetanide at a concentration
(i.e., 10 µM) that inhibits SCN excitatory responses to GABA in vitro (Choi et al., 2008; Irwin
and Allen, 2009; Alamilla et al., 2014; Farajnia et al., 2014; Kim et al., 2016), reduced the
phase delays produced by light by approximately 50% (Fig. 2.1). Further support for the
possibility that bumetanide acts to reduce the ability of light to induce phase delays was the
finding that bumetanide did not alter circadian phase in the absence of a light pulse at CT 13.5
(Fig. 2.2).
In the late subjective night (i.e., CT 19), injection of bumetanide into the SCN region did
not reduce light-induced phase advances (Fig. 2.3). Furthermore, the injection of bumetanide
into the SCN in the late subjective night in the absence of light did not lead to significant phase
shifts of the rhythm at any concentration (Fig. 2.4). These differences suggest a different role for
GABAAR-induced excitation in light-induced phase delays and phase advances or possibly no
role for GABAAR excitatory responses in light-induced advances. Our lab has previously shown
that the GABAAR agonist muscimol attenuates light-induced phase delays and advances in both
night-active and day-active species (Gillespie et al., 1997; Novak and Albers, 2004a). However,
injection of the GABAAR antagonist bicuculline into the SCN region potentiates light-induced
phase delays in the early night but not light-induced phase advances in the late night (Gillespie et
al., 1997). In contrast, however, microinjection of bicuculline before phase delaying or phase
advancing light pulses increases c-Fos-immunoreactivity within the SCN (Gillespie et al., 1999).
Different GABAAR mechanisms may be involved in mediating light-induced phase delays and
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phase advances that may involve phase dependent changes in the excitatory/inhibitory ratio of
GABAAR containing SCN neurons and phase dependent changes in GABAAR subunit
composition (Choi et al., 2008; Irwin and Allen, 2009; Walton et al., 2017).
To determine if the phase advances mediated by activation of GABAARs in the subjective
day (i.e., CT 6) require NKCC1 activity, we examined the effects of bumetanide on muscimolinduced phase advances. As expected, injection of muscimol into the SCN region produced
phase advances when compared with injections of vehicle (Fig. 2.6). Injection of bumetanide
into the SCN in the subjective day did not induce phase shifts that differed from vehicle (Fig.
2.5). The injection of muscimol combined with bumetanide inhibited muscimol-induced phase
advances when bumetanide was added at a concentration of 100 µM. No significant reductions in
muscimol-induced phase advances were observed when bumetanide was co-administered at
concentrations of 10 µM or 1 mM (Fig. 2.6).
The present experiments are the first to examine whether the NKCC1 inhibitor,
bumetanide, influences the phase of the circadian pacemaker by its actions within the
SCN in vivo. Prior work has focused on the effects of bumetanide on the cellular
responses of SCN neurons monitored in vitro. These in vitro studies have found that µM
concentrations of bumetanide (i.e., 10-100 µM) inhibit the excitatory effects of GABA within the
SCN (Choi et al., 2008; Irwin and Allen, 2009; Alamilla et al., 2014; Farajnia et al., 2014;
Kim et al., 2016). Bumetanide has a 500-fold greater affinity for NKCCs than KCCs, thus low
bumetanide concentrations (up to 100 µM) can be used in vitro to inhibit NKCCs without
affecting KCCs, as observed in non-SCN brain tissue (Gamba, 2005). However, at higher
concentrations, bumetanide begins to inhibit chloride efflux via actions on KCCs (Gamba, 2005;
Delpire et al., 2009). These concentration dependent off-target actions of bumetanide on chloride
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efflux proteins (KCCs) may explain why we did not observe any circadian effects of 1 mM
bumetanide at any time during the cycle. The effects of higher concentrations of bumetanide on
SCN cellular activity in vitro, however, are not known as no dose-response work above 100 µM
has been performed in the SCN, to our knowledge. Future work employing microinjections of
specific KCC2 inhibitors (e.g. VU024551) will be needed to address the functional role of
KCC2, as well as other KCCs (1, 3, and 4) expressed in the SCN (Belenky et al., 2010; Klett
and Allen, 2017).
Importantly, the ratio of GABA-induced excitation to inhibition in SCN neurons changes
over the circadian cycle, as shown in multiple studies, although the exact temporal pattern of
these changes is not clear, with reports of GABA-induced excitation occurring in the day, the
night, or both (Wagner et al., 1997; Choi et al., 2008; Irwin and Allen, 2009; Alamilla et al.,
2014; Farajnia et al., 2014). GABA excitation of SCN neurons may also differ in the vSCN and
dSCN subregions, though these findings are also not consistent. Dorsal SCN neurons are more
likely to display EPSPs upon GABA application and NKCC1 protein may be higher in the dSCN
at night, though others have reported no differences (Choi et al., 2008; Belenky et al., 2010).
Optic chiasm stimulation of the RHT or GABA application are more likely to increase the
intracellular calcium concentration ([Ca2+i]) in the dSCN (Irwin and Allen, 2009). Klett and
Allen 2017 used chloride sensors to show that bumetanide causes small changes in intracellular
chloride concentration ([Cl-i]). Surprisingly, bumetanide increases [Cl-i] in AVP+ neurons, and
decreases [Cl-i] in VIP+ neurons. KCC antagonism increases [Cl-i] in both AVP+ and VIP+ SCN
neurons, as expected, upon inhibition of the chloride efflux protein. In addition, bumetanide
blocks the effects of a specific KCC2 antagonist on [Cl-i], suggesting NKCC1 is regulating
chloride influx in SCN neurons, as shown in other brain regions (Klett and Allen 2017).
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Furthermore, we can not rule out the possibility that our microinjection of NKCC1 inhibitor
acted on non-AVP+ and/or or non-VIP+ SCN neurons as we applied the inhibitor to the entire
SCN region and these cells comprise a small percentage of total SCN network neurons; VIP ≈
10% and AVP ≈ 20% (Welsh et al., 2010). Inhibition of NKCC1 in non-AVP/VIP cells may be
responsible for the modulation of phase shifts. Of course, the data of the present study cannot
discriminate among these possibilities. However, it is important to note that most, if not all, of
these neuropeptidergic cells co-localize with GABA in SCN neurons (Moore and Speh, 1993). It
is also possible that our injections of bumetanide may have had an effect on glycinergic signaling
within the SCN as glycine receptors also mediate a chloride current in SCN neurons and their
activation may induce phase advances during the subjective day and phase delays in the early
night (Ito et al., 1991; Mordel et al., 2011). However, our findings in the subjective day suggest
that bumetanide inhibits phase advances directly signaled by the GABAAR as we inhibited
subjective day advances induced by the GABAAR agonist muscimol. In addition, no in vivo
work, to our knowledge, explores the role of glycine in SCN mechanisms of entrainment to light.
Importantly, the differences observed in the present study suggest that the effects of
bumetanide within the SCN are both phase and concentration dependent, consistent with
observations made in vitro. Concentrations of bumetanide that dramatically inhibit the excitatory
effects of GABA in vitro reduce the phase delaying effects of light at CT 13.5. These data are
consistent with a theoretical model in which endogenously released GABA is proposed to
increase depolarization in response to RHT signaling in neurons with a higher ratio of
NKCC1/KCC2 activity (i.e., excitatory to inhibitory), but to induce hyperpolarization in
response to RHT signaling in neurons with a lower ratio of NKCC1/KCC2 activity (Irwin and
Allen, 2009). The findings of the present study provide support for this model and significantly
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extend it by demonstrating that the excitatory effects of endogenously released GABA at CT
13.5 contribute to the ability of light to induce phase delays; thereby contributing to the most
important function of the circadian system, its entrainment with the day-night cycle. Indeed,
reduction of the excitatory effects of endogenously released GABA reduces the phase delay
produced by light at CT 13.5 (Fig. 2.1).
Importantly, activation of the RHT produces GABA-induced excitatory responses in
some SCN neurons and GABA-induced inhibitory responses in other SCN neurons (Irwin and
Allen, 2009). Likewise, the present data indicate that GABA released in response to RHT
activation enhances light-induced phase delays, while previous work has found that GABAA
antagonists can enhance and GABAA agonists can inhibit light-induced phase delays at CT 13.5
(Gillespie et al., 1996). How can endogenously released GABA enhance light-induced phase
delays and also inhibit light-induced phase delays? Perhaps these opposite effects of GABA are
the result of GABAAR activation in different subregions or on subsets of neurons within the SCN
with different NKCC1/KCC ratios. For example, the enhancement of light-induced phase delays
could be mediated by the excitatory effects of GABA endogenously released in the dSCN
whereas the inhibitory effects of GABA on light-induced phase delays could be mediated by
activation of GABAA receptors in the retinoreceptive vSCN. The inhibitory effects of GABA on
light-induced phase delays could be the result of the inhibition of RHT signaling to the vSCN
and/or the inhibition of GABA release in neurons that project from the ventral to the dSCN. In
support of this idea are the findings that more NKCC1 activity is seen in the dSCN and that the
excitatory effects of GABA may be proportionally greater in the dSCN than in the vSCN,
particularly during the night (Choi et al., 2008; Irwin and Allen, 2009).
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In addition to the acute effects of activating or inhibiting SCN GABAARs on the ability
of light to induce phase delays, the sustained activation of GABAARs appears to be necessary for
light to induce phase delays at CT 13.5 (Hummer et al., 2015). Because phase delaying pulses of
light produce a sustained activation of SCN neurons that lasts more than four hours, and the SCN
is a largely GABAergic network, it seems likely that there is a corresponding sustained release of
GABA in the SCN (Hamada et al., 2001;

Kuhlman et al., 2003;

LeSauter et al., 2011;

DeWoskin et al., 2015). Support for the hypothesis that the sustained activation of GABAARs in
the SCN is necessary for the phase delaying effects of light comes from the findings that
injection of muscimol into the SCN beginning at CT 13.5 must occur over at least four hours to
mimic phase delays to light and that the injection of bicuculline must be given for six
consecutive hours to block the phase delaying effects of light (Hummer et al., 2015). Whether
the ability of the sustained activation of GABAARs to produce phase delays is the result of
excitatory, inhibitory, or bipolar responses to GABA is not known. One hypothesis that would be
consistent with the existing data is that the sustained activation of GABAA receptors produces
sustained excitatory responses (perhaps in the dSCN) and the sustained excitatory responses are
necessary to phase delay the pacemaker (Choi et al., 2008; DeWoskin et al., 2015; Hummer et
al., 2015). If correct, this hypothesis might also explain why bumetanide inhibits light-induced
phase delays in the present study because bumetanide would reduce the duration of the excitatory
responses to GABA induced by light.
During the subjective day, bumetanide inhibited the ability of muscimol to induce phase
advances, supporting the hypothesis that excitatory responses to GABA contribute to the phase
advancing effects of muscimol at CT 6 (Fig. 2.6). A functional role for the excitatory effects of
GABA during the day is consistent with electrophysiological evidence reporting that GABA has
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primarily excitatory effects on SCN neurons during the day (Wagner et al., 1997; Alamilla et al.,
2014). Even in several of the studies that found GABA’s excitatory effects to occur primarily
during the night, a significant number of excitatory responses to GABA and muscimol were also
observed during the day (Choi et al., 2008; Irwin and Allen, 2009). Because activation of
GABAA receptors appears to be necessary for the phase shifting effects of NPY as well as other
non-photic phase shifting stimuli, the excitatory effects of GABA may be partially responsible
for mediating these non-photic shifts. Thus, these data provide further support for the hypothesis
that GABA’s excitatory effects in the SCN play an important functional role in circadian
timekeeping.
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3
3.1

NKCC1 PROTEIN EXPRESSION IN THE SCN OF SYRIAN HAMSTERS

Introduction
The suprachiasmatic nucleus is a GABAergic network that controls the phase of daily

rhythms and entrains these rhythms in physiology and behavior in mammals to the external light
dark cycle (Moore and Eichler, 1972; Stephan and Zucker, 1972; Cohen and Albers, 1991). The
SCN is composed of 16-20,000 neurons in bilaterally paired nuclei situated in the anterior
hypothalamus (Moore et al., 2002a). Although the functional significance of its sub-regions is
still debated, much evidence suggests that the SCN contains functionally distinct neuronal subpopulations with differing neuropeptide content, daily electrical activity, and clock gene
expression (Antle et al., 2005b;

Albers et al., 2017).

In Syrian hamsters, for example,

ventrolateral (“core”) SCN neurons (vSCN) receive the bulk of the input from the
retinohypothalamic tract (RHT) and few neurons display rhythmic neuronal firing and clock
gene expression. In contrast, dorsal (“shell”) SCN neurons (dSCN) receive much less retinal
input and display robust electrical and clock gene rhythmicity (Bryant et al., 2000; Hamada et
al., 2001; Jobst and Allen, 2002). Importantly, evidence also suggests the retinorecipient vSCN
communicates phase information to the dSCN and ultimately adjust the phase of these oscillators
(Leak et al., 1999; Albus et al., 2005; Albers et al., 2017; Taylor et al., 2017).
γ-amino butyric acid (GABA) is produced in most neurons of the SCN and 30+ years of
both in vivo and in vitro studies describe a role for GABA in phase shifting as well as
synchronization of the network (Ralph and Menaker, 1985; van den Pol and Tsujimoto, 1985;
van den Pol and Gorcs, 1986; Okamura et al., 1989; Moore and Speh, 1993; O'Hara et al.,
1995; Gillespie et al., 1999; Castel and Morris, 2000a; Liu and Reppert, 2000; Novak and
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Albers, 2004a; Albus et al., 2005; Albers et al., 2017). GABA is most commonly described in
the CNS as an inhibitory amino acid neurotransmitter; however, it is becoming increasingly clear
that this classic neurotransmitter can also lead to excitation in both the CNS and PNS. Cation
chloride cotransporters (CCCs) are crucial regulators of chloride equilibrium that are critical in
determining if GABA binding to its ionotropic GABAA receptor (GABAAR) is hyperpolarizing
or depolarizing (Xu et al., 1994; Gillen et al., 1996; Payne et al., 1996; Markadieu and Delpire,
2014). GABA excitation in many brain regions, including the SCN, is dependent on the actions
of Na-K-2Cl cotransporters, (NKCCs) as these proteins transport chloride ions (stoichiometry
1Na+: 1K+: 2Cl-) into cells. NKCC1 is the most prevalent NKCC isoform in the CNS. As GABA
binding opens a GABAAR chloride ion pore, the likelihood of GABA leading to depolarization
of a neuron is partially determined by the activity and expression level of this chloride influx
cotransporter, NKCC1 (For review: (Markadieu and Delpire, 2014).
Neuronal responses to GABA in the SCN have been extensively studied, yet there is not a
consensus as to its actions within the nuclei (Wagner et al., 1997; Liu and Reppert, 2000; De
Jeu and Pennartz, 2002; Itri et al., 2004; Albus et al., 2005; Aton et al., 2006; Choi et al., 2008;
Irwin and Allen, 2009; Myung et al., 2012; Freeman et al., 2013; Farajnia et al., 2014; Albers
et al., 2017). For instance, some reports suggest GABA is exclusively inhibitory, yet others
report that GABA is predominantly excitatory during the day, and still others suggest excitation
to GABA is more prevalent during the night (Liou and Albers, 1990; Wagner et al., 1997; Choi
et al., 2008; Irwin and Allen, 2009; Alamilla et al., 2014). To complicate matters, there is also a
lack of consensus about when the dSCN and vSCN are excited and/or inhibited by GABA.
Multiple studies suggest that NKCC1 is expressed in most neurons of the dSCN and vSCN,
regardless of time of day or sub-compartment, and excitatory responses to GABA in the adult
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SCN are blocked by inhibition of NKCC1 with the loop diuretic bumetanide (Choi et al., 2008;
Irwin and Allen, 2009;

Belenky et al., 2010) We have recently shown that endogenous

excitatory responses to GABA may be a part of the mechanisms regulating phase shifts to light
as well as non-photic-like shifts of the SCN in vivo (McNeill et al., 2018)(Chapter 2).
Seminal work on the circadian clock wisely described the SCN as a “Clock for All
Seasons” (Pittendrigh and Daan, 1976b). To this point, CCCs at the level of the SCN may
respond to changes in light duration (i.e. photoperiod). Long day exposure has been shown to
increase the percentage of SCN neurons excited by GABA (Farajnia et al., 2014). In addition,
GABAAR signaling may be a major regulator of SCN neuronal mechanisms of phase shifting
and synchronization via both excitation and inhibition. It seems likely that changes in chloride
co-transporter expression may encode both light duration and serve circadian functions such as
entrainment of circadian rhythms to light. Thus, we tested the hypothesis that NKCC1 protein
expression in the SCN is regulated by the duration of environmental lighting. We also tested the
hypothesis that NKCC1 displays daily and circadian changes in the intact circadian system of the
Syrian hamster.
3.2
3.2.1

Materials and methods
Animals, light treatment, and activity monitoring
Adult male Syrian hamsters (approximately 9-10 weeks; 120-140g) were purchased from

Charles River Labs. Upon receipt, hamsters were individually housed in polycarbonate cages
with running wheels (Tecniplast) equipped with magnetic switches to record activity. Food (Lab
Diet-#5001, Nestle Purina Pet Care, St. Louis, MO) and water were provided ad libitum. Animal
facility staff used a Kodak LED Safelight (660 nm) for routine animal husbandry. Activity was
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monitored as wheel revolutions/10 minutes and collected with VitalView Software (Mini Mitter,
Bend, OR, USA). These cage setups were placed into light tight housing chambers and held in a
14:10 light: dark (LD) cycle for 14 days (25° ± 1° C; 200 lux at cage tops). Housing in this way
allows the animals to acclimatize to the animal facility and also standardizes the recent
photoperiodic exposure of all experimental animals to diminish the aftereffects of prior
entrainment. After the acclimatization period (14 days), including actogram confirmation that
each hamster was entrained to the LD 14:10 cycle, the lights within the light tight circadian
chambers were either kept as LD 14:10 (200 lux) or changed to constant dark (DD) or constant
light (LL)(200 lux) conditions for an additional 14 days. Housing Syrian hamsters in LD 14:10
decreases the chance of individual animals adopting a short day phenotype. Hamsters were
sacrificed at zeitgeber times (ZT) 1, 6, 13.5, and 19 for animals housed in LD and circadian
times (CT) 1, 6, 13.5, and 19 for animals housed in DD or LL. Regression lines were fit to
activity onsets for 7-10 days before sacrifice to determine the onset of activity in free-running
conditions (DD and LL)(ClockLab; Actimetrics, USA). By convention, CT 12 was defined as the
time of activity onset. All procedures conformed to National Institutes of Health guidelines and
were approved by the Institutional Animal Care and Use Committee of Georgia State University.
3.2.2

NKCC1 protein expression in the SCN
At the end of the 14 days in all three lighting conditions (LD, DD, LL), hamsters were

administered a lethal dose of sodium pentobarbital (200 mg/kg) and transcardially perfused with
0.1 M phosphate buffered saline (PBS-150 mL, pH 7.4) followed by 4% paraformaldehyde in
PBS (150 mL, pH 7.4). Sodium pentobarbital injections were performed in dim red light (5 lux)
and the eyes were covered during perfusion to block the effects of acute light exposure on
protein expression. The brains were removed and post-fixed for an additional 20 h in 4%
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paraformaldehyde then moved to 20% sucrose for cryo-protection until sectioning (2-4 days).
Coronal sections of brain were cut at 40 µm on a cryostat and collected in cryoprotectant (30%
w/v sucrose, 1% w/v PVP-40, 30% v/v ethylene glycol in 0.9% NaCl phosphate buffer) and
stored at -20° C until immunohistochemical processing.
Immunohistochemistry was yoked such that all tissue was simultaneously processed for
NKCC1 protein expression to allow for comparison of relative protein expression within and
between lighting conditions. Briefly, free floating tissue sections were rinsed 4x in 0.1 M PBS at
RT then transferred to 10 mM sodium citrate buffer (80° C, pH 8.5) for 30 min for antigen
retrieval. After tissue returned to RT (30 minutes), sections were rinsed 3x in PBS w/ 0.3% v/v
Triton X-100 (PBS-T) then transferred to 0.3% hydrogen peroxide to quench endogenous
peroxidases (20 min at RT). Next, the sections were rinsed 3x in PBS-T, blocked in 10% v/v
normal donkey serum (NDS) in PBS-T for 2 h at RT, and incubated in primary antibody
targeting NKCC1 (Abcam #99558 1:500 in 0.5% NDS v/v in PBS-T (1 h at RT, 48 h at 4° C).
Following primary antibody incubation, tissue was rinsed 4x in 5% NDS in PBS-T and then
incubated in secondary antibody (1:500; Peroxidase AffiniPure Donkey Anti-Goat IgG (H+L),
Jackson Immuno 705-035-147) in 5% NDS in PBS-T (2 h at RT). Next, sections were rinsed 3x
in PBS-T and then exposed to tyramide signal amplification for 10 minutes (1:300, PerkinElmer,
Fluorescein Plus Amplification Reagent in 1x Plus Amplification Diluent, NEL74100). We
found this amplification step necessary to increase the intensity of the fluorescent signal
(Belenky et al., 2010). After signal amplification, tissue was rinsed 3x in 0.1 M PBS then
mounted onto double gelatin-coated slides (300 bloom gelatin, Sigma Aldrich, with chromium
potassium sulfate dodecahyrdrate) with VectaShield HardSet Anti-Fade Mounting Medium with
4,6-diamidino-2-phenylindole (DAPI)(H-1500, Vector Laboratories).
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3.2.3

Representative SCN tissue
Early neuroanatomical studies using rat brain tissue describe main neuropeptidergic sub-

regions of the SCN as ventrolateral (core) (vSCN) and dorsomedial (shell) (dSCN) (van den Pol
and Tsujimoto, 1985). However, these divisions show differences between species and
controversy still remains about the functional significance of these neuroanatomical subdivisions (Moore et al., 2002a; Lee et al., 2003; Morin and Allen, 2006; Morin, 2007; Evans,
2016; Albers et al., 2017). Further, GABAAR subunit distribution may vary on the dorsoventral
and rostrocaudal axes of the nucleus (Gao et al., 1995; Belenky et al., 2003; Walton et al.,
2017). Due to these differences, we chose a representative section from each animal that includes
both the ventrolateral retinorecipient (Calbindin-containing region) of the hamster SCN as well
as vasopressin expression in the dorsal aspect (Hamada et al., 2001). The sections correspond to
the third quadrant of the rostro-caudal extent of the Syrian hamster SCN and the vasopressin
containing region dorsal and medial to these cells as described in Hamada 2001 (Silver et al.,
1996; Hamada et al., 2001; Lee et al., 2003; Yan et al., 2005).
3.2.4

Microscopy and quantification
All immuno-fluorescent images were captured at 40x for whole SCN and 100x for sub-

regional relative quantification with a Keyence BZ-X700 All-in-one fluorescence microscope.
DAPI immunofluorescence images were taken using a Keyence BZ-X DAPI filter (OP-87762)
with excitation and emission wavelengths of 360 and 460, respectively. Fluorescein
immunofluorescence was captured with a Keyence BZ-X GFP filter (OP-87763) with excitation
and emission wavelengths of 470 and 525, respectively (Keyence Corporation, Itasca, IL).
Images were captured using the Keyence high-resolution 2.8 megapixel monochrome chargecoupled-device (CCD) camera.
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3.2.5

Image analysis
For whole SCN analysis, ImageJ (NIH, Bethesda, MD) was used to define a region of

interest (ROI) that included an entire unilateral SCN from this level as defined by dense SCN
DAPI fluorescence. A ROI was drawn using a 150 µm circle in both the vSCN and dSCN
regions for sub-region comparisons. All images for relative fluorescence quantification were
taken without altering microscope or camera settings to allow for comparison within and
between lighting conditions. Relative fluorescence was quantified using ImageJ software.
Briefly, images were converted to 8-bit black and white images and gray scale values were
measured (0-255) to quantify relative protein-immunoreactivity within the ROI. An observer
made measurements blind to the experimental group of each hamster.
3.2.6

NKCC1 gene expression in the SCN
Animals were handled before sacrifice as described above for immunohistochemical

experiments. After 14 days in either LD or DD, hamsters were administered a lethal dose of
sodium pentobarbital, decapitated, and brains were quickly removed under dim red light (< 5
lux) and placed in RNAlater (Ambion). The brains remained in this solution at 4° C until RNA
extraction. Animals were sacrificed, at the same time points described above (i.e. ZT 1, ZT 6, ZT
13.5, and ZT 19 for LD and CT 1, CT 6, CT 13.5, and CT 19 for DD). As in Walton 2017,
briefly, the SCN was collected by placing brains in a matrix and, using a 1.0 mm tissue punch,
collected into 200 µl of Trizol (Ambion). The SCN were homogenized in 1.0 ml Trizol with a
sterile pestle and RNA extraction was performed following the manufacturer’s protocol
(Ambion). RNA samples were washed 2x in chloroform and precipitated with 100% isopropanol.
The resulting pellet was washed 2x with 75% ethanol and resuspended in 20 µl of water. A
NanoDrop 2000 was used to determine RNA concentration. After the extraction step, 150 ng of
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total RNA was reverse transcribed into cDNA with M-MLV (Promega) according to the
manufacturer’s protocol. An ABI 7500 FAST Real-Time system was used to quantify relative
gene expression along with Taqman Universal PCR master mix. The two-step RT-PCR cycles
used were as follows: 50° C for 12 min, 95 ° C for 10 min, 40 cycles of 95 ° C for 15 sec, and
60° C for 1 min. The primer/probe set was Mm01265951_m1 (Cat. #433182) from Applied
Biosystems (Walton et al., 2017). Samples were run in duplicate and relative gene expression
was derived by comparison to a relative standard curve standardized to 18S rRNA expression.
The relative cDNA standards came from pooled hippocampal RNA extracts from animals at each
LD and DD time point.
3.2.7

Statistical analyses
Statistical analyses were performed using SPSS 22.0 (IBM). Data are represented as

relative NKCC1 protein-IR (gray scale value) ±SEM. For whole SCN data a one-way ANOVA
was used to determine the effect of lighting condition on relative protein-IR followed by a
Tukey’s HSD post hoc test for significant ANOVAs. ANOVA was used for each lighting
condition to determine the effect of zeitgeber time or circadian time (LD, DD, and LL) on
protein-IR and relative gene expression (LD and DD) followed by Tukey’s HSD post hoc testing
for multiple comparisons of time of day. A repeated measures ANOVA was used to determine
the effects of time of day (between factor) and sub-region (within factor) on protein-IR within
each lighting condition. When main effects were detected by ANOVA, paired t-tests at each time
point were used to compare sub-regions. Significance was set at p ≤ 0.050.
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3.3
3.3.1

Results
Effect of lighting conditions on NKCC1 protein expression in the SCN
NKCC1-IR was observed throughout the SCN in animals from all light regimens. This

diffuse expression has been previously reported in rats (Belenky et al., 2010). As mentioned
above, we measured and analyzed protein-IR in the whole SCN as well as in the vSCN and
dSCN. ANOVA revealed that adult male hamsters housed in LD, DD, or LL had different levels
of NKCC1 protein expression in the whole SCN (F(2,56)=10.129, p=0.0002). Tukey’s HSD post
hoc testing revealed that hamsters housed for 14 days in LL (200 lux) exhibited higher SCN
NKCC1 protein expression than those housed in either LD 14:10 or DD (p=0.0001 and p=0.001,
respectively). There were no differences in overall NKCC1 protein expression in whole SCN
between hamsters housed in LD or DD (p > 0.05)(Fig. 3.1).
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Figure 3-1: Effect of lighting condition on NKCC1 protein
Constant light conditions (LL=200 lux) increased NKCC1 protein-IR in the SCN
(F(2,56)=10.129, p=0.0002). Means represent all animals within lighting condition regardless of
time of sacrifice. Tukey’s HSD post hoc test revealed that LL increased protein-IR as compared
with both LD and DD light cycles (p=0.0001 and p=0.001, respectively). *(p < 0.05)
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3.3.2

NKCC1 protein expression in the whole SCN (LD, DD, and LL)
Next, to determine if NKCC1 protein expression varies over the circadian cycle in each

of the lighting conditions, we analyzed each light regimen by one way ANOVA with grayscale
value as the dependent variable and either zeitgeber time (LD) or circadian time (free-running
groups in DD and LL) as the independent variable. Zeitgeber time did not affect NKCC1 proteinIR in the SCN (F(3,15)=0.075, p=0.972) (Fig. 3.2).

Figure 3-2: NKCC1 expression in LD 14:10
When hamsters were housed in LD 14:10, zeitgeber time did not affect NKCC1 proteinIR in the SCN (F(3,15)=0.075, p=0.972).
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Hamsters housed in DD or LL for 14 days, however, showed circadian time dependent
differences in NKCC1 protein-IR. For hamsters housed in DD, NKCC1 protein-IR was at its
lowest in the early subjective night (CT 13.5) (F(3,16)=4.542, p=0.017). Tukey’s post hoc testing
revealed that NKCC1 protein expression was lower in the early subjective night than both the
early subjective day and the late subjective night (p=0.040 and 0.033, respectively). NKCC1
protein-IR in the middle of the subjective day (CT 6) did not differ from any other circadian time
point (p > 0.05)(Fig. 3.3).
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Figure 3-3: NKCC1 protein expression in constant dark (DD)
For hamsters housed in constant dark, circadian time alters NKCC1 protein-IR
(F(3,16)=4.542, p=0.017). NKCC1 protein in the early subjective night (CT 13.5) was lower than
both early subjective day (CT 1) and late subjective night (CT 19) (p=0.040 and 0.033,
respectively). NKCC1 protein-IR in the middle of the subjective day (CT 6) did not differ from
any other circadian time (p > 0.05). *(p < 0.05)
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Hamsters housed in LL for 14 days also displayed circadian dependent differences in
NKCC1 protein-IR (F(3,16)=3.982, p=0.027). Interestingly, the pattern of NKCC1 protein-IR was
different from that of hamsters housed in DD. NKCC1 protein-IR was at its lowest in the late
subjective night (CT 19) and statistically different from the early subjective day (CT 1)
(p=0.026). Although NKCC1 protein-IR in the middle of the subjective day (CT 6) and early
subjective night (CT 13.5) did not statistically differ from other circadian times, a general trend
was observed for NKCC1 protein to decrease across the circadian day (LL) (p > 0.05)(Fig. 3.4).
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Figure 3-4: NKCC1 protein expression in constant light (LL)
When hamsters were housed in constant light (200 lux) circadian time alters NKCC1
protein-IR, though the pattern of NKCC1 expression was different than in DD (Fig. 3)
(F(3,16)=3.982, p=0.027). NKCC1 protein-IR was elevated in the early subjective day (CT 1) as
compared to the late subjective night (CT 19) (p=0.026). NKCC1 protein-IR in the middle of the
subjective day (CT 6) and the early subjective night (CT 13.5) did not differ from other circadian
times. *(p < 0.05).
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3.3.3

NKCC1 protein expression in the vSCN and dSCN (LD, DD, and LL)
As discussed above, the vSCN and dSCN are commonly described as major sub-

compartments within the SCN (Moore et al., 2002a; Lee et al., 2003; Yan et al., 2007; Albers
et al., 2017; Taylor et al., 2017). Thus, we measured NKCC1 protein-IR in these important subregions using the same brain sections used for whole SCN analysis.

Repeated measures

ANOVA from animals housed in LD revealed a main effect of sub-region of the SCN on
NKCC1 protein-IR (F(1,15)=8.866, p=0.009). Overall, lower NKCC1 protein-IR was observed in
the dSCN as compared with the vSCN. However, this appears to be a general trend across the
LD cycle as paired t-tests at each zeitgeber time point from which animals were sacrificed did
not show differences between dSCN and vSCN (ZT 1, t=1.580, p=0.189; ZT 6, t=0.602,
p=0.590; ZT 13.5, t=1.754, p=0.154; ZT 19, t=2.202, p=0.092)(Fig. 3.5).
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Figure 3-5: NKCC1 expression in LD; vSCN and dSCN
A repeated measures ANOVA unveiled a main effect of SCN region on NKCC1 protein
expression (F(1,15)=8.866, p=0.009), but no interaction with ZT. However, lower dorsomedial
SCN NKCC1 protein-IR appears to be a general trend across the LD cycle. Paired t-tests for each
time point did not reveal DM/VL differences (ZT 1, t=1.580, p=0.189; ZT 6, t=0.602, p=0.590;
ZT 13.5, t=1.754, p=0.154; ZT 19, t=2.202, p=0.092).

94

As observed in hamsters housed in LD, repeated measures ANOVA showed that NKCC1
protein-IR was lower in the dSCN than in the vSCN in hamsters housed in DD (F(1,16)=5.665,
p=0.030). In contrast to NKCC1 expression in hamsters housed in LD, paired t-tests revealed
that dSCN NKCC1 protein-IR in the late subjective night (CT 19) was lower than vSCN protein
expression (t=3.142, p=0.035). Paired t-tests did not reveal differences in dSCN and vSCN
NKCC1 protein-IR at any other circadian time point (CT 1, t=0.900, p=0.419; CT 6, t=1.781,
p=0.135; CT 13.5, t=0.687, p=0.541) (Fig. 3.6). This finding suggests the possibility that overall
differences in whole SCN NKCC1 protein expression in hamsters housed in DD may be driven
by increases in the retino-recipient SCN, possibly in the late subjective night (Fig. 3.3).
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Figure 3-6: NKCC1 protein expression in DD; vSCN and dSCN
Dorsomedial NKCC1 protein-IR was lower than ventrolateral NKCC1 protein-IR in
hamsters housed in DD as revealed by repeated measures ANOVA (F(1,16)=5.665, p=0.030).
Paired t-tests revealed that at CT 19, dorsomedial NKCC1 protein was lower than ventrolateral
NKCC1 protein (t=3.142, p=0.035). At all other time points (CT 1, CT 6, CT 13.5) paired t-tests
did not reveal differences in NKCC1 protein-IR (CT 1, t=0.900, p=0.419; CT 6, t=1.781,
p=0.135; CT 13.5, t=0.687, p=0.541).
Unlike the sub-regional differences observed in both LD and DD conditions, repeated
measures ANOVA of NKCC1 protein-IR in hamsters housed in LL did not show a main effect of
SCN sub-region (F(1,15)=1.606, p=0.224)(Fig. 3.7). This finding suggests that both the overall
increases observed in hamsters in LL as well as high early day expression of NKCC1 may be
driven by NKCC1 protein increases throughout both sub-regions of the SCN.

Figure 3-7: NKCC1 protein expression in LL; vSCN and dSCN
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As opposed to both LD and DD conditions, repeated measures ANOVA revealed no
effect of SCN sub-region on NKCC1 protein-IR (F(1,15)=1.606, p=0.224)
3.3.4

NKCC1 gene expression in the SCN (LD and DD)
One-way ANOVA of relative Slc12a2 (Nkcc1) gene expression in the SCN, with time of

day as the independent variable, showed no differences across the day in entrained or in freerunning animals (p > 0.05). However, there appears to be a trend towards a decrease in mRNA at
the day to night and subjective day to subjective night transitions (Fig. 3.8).

Figure 3-8: NKCC1 mRNA in LD and DD
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NKCC1 mRNA did not differ across the day in a light dark cycle or in hamsters housed
in constant dark (p > 0.05).
3.4
3.4.1

Discussion
NKCC1 protein in different lighting conditions
Constant light, as compared with both LD and DD conditions increased overall SCN

NKCC1 protein-IR. The differences in NKCC1 protein levels in these different conditions
support the hypothesis, posited by multiple authors, that the duration of light may be encoded at
the level of the SCN (Pittendrigh and Daan, 1976b; Pohl, 1983; Pittendrigh, 1984; Humlova
and Illnerova, 1992; Travnickova et al., 1996; Vuillez et al., 1996; Sumova and Illnerova,
1998;

vanderLeest et al., 2009). This encoding most likely involves changes in NKCC1

expression within the SCN that, in turn, tune the excitatory/inhibitory balance of the neurons of
the pacemaker (Farajnia et al., 2014; Myung et al., 2015a).
3.4.2

Photoperiod, NKCC1, and excitation by GABA
Researchers have addressed the effects of light duration on the ratio of SCN neurons

excited:inhibited by GABA. For example, SCN neurons from mice housed in long days respond
to GABA with excitation more than SCN neurons from mice in equinoctial or short day
conditions. Specifically, 40% of LD 16:8 SCN neurons show excitatory Ca2+ transients to GABA
application while 32% are inhibitory. This ratio switches to 28% to 52% (excite to inhibit) in LD
8:16, while the equinoctial group is intermediate in responsiveness (Farajnia et al., 2014). This
led to the hypothesis that the ratio of SCN neurons excited: inhibited by GABA could be
involved in encoding photoperiod at the level of the SCN. Long days (16:8) also increase the
ratio of NKCC1/KCC2 mRNA and total intracellular chloride versus the short day (8:16), in the
dSCN and vSCN using RT-qPCR (Myung et al., 2015a).
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Circadian rhythms are able to entrain to both short and long photoperiods with different
numbers of neurons phase-dependently responding to GABA with excitation and
inhibition(Farajnia et al., 2014). However, phase-resetting responses are smaller in animals from
long day photoperiods versus short day animals (Pittendrigh, 1984;

Evans, 2016). A

parsimonious hypothesis emerges suggesting the increased ratio of SCN neurons
excited:inhibited by GABAAR binding in the long day makes the system less responsive to
incoming zeitgebers. NKCC1 activity may work in concert with other CCCs to regulate the
magnitude of light-signaled phased shifts by influencing the number of SCN neurons that adjust
to the new phase. For example, we recently showed that injection of the NKCC1 inhibitor
bumetanide into the SCN region decreases behavioral phase delays to light in the early subjective
night and blunts phase advances induced by the GABAAR agonist muscimol in the middle of the
subjective day (McNeill et al., 2018).
In addition, these long day increases in the excitatory:inhibitory balance in the SCN may
be involved in the phase expansion of electrical activity observed in long days (Mrugala et al.,
2000; VanderLeest et al., 2007). The current data add to these findings and are consistent with
the suggestion that one mechanism through which this may occur is increases in NKCC1 protein,
leading to increases in intracellular chloride, and ultimately a depolarizing shift in EGABA. This
increase in excitatory:inhibitory balance in long days is blocked by the NKCC1 inhibitor
bumetanide (Farajnia et al., 2014). Surprisingly, we did not observe a difference between our DD
and LD group in overall NKCC1 expression, though it is important to consider differences in
species and experimental design as our animals were free-running in constant dark and constant
light while others used varying LD cycles (e.g. LD 8:16, LD 12:12, and LD 16:8). Our data are

99

the first in the Syrian hamster, to our knowledge, to show increases in NKCC1 protein in the
SCN as the duration of light increases (e.g., LL vs. LD).
3.4.3

NKCC1 protein and time dependency (ZT and CT)
We also observed different circadian profiles of NKCC1 protein-IR in animals housed in

both DD and LL, but not animals entrained to an LD cycle. Briefly, NKCC1 protein in the SCN
of animals housed in DD peaked in the late subjective night and early subjective day while
NKCC1 protein was lowest in the early subjective night (Fig. 3.3). In contrast, when hamsters
were housed in LL, NKCC1 protein peaked in the early subjective day, similar to DD, but
declined throughout the day with expression at its lowest in the late subjective night (Fig. 3.4). It
is possible that light duration effects on NKCC1 protein account for the differences we observed
between NKCC1 protein levels in animals housed in LL versus DD.
3.4.4

NKCC1 protein antigenic sites
An important point for consideration is that there are two identified main splice variants

of Slc12a2 (Nkcc1), Nkcc1a and Nkcc1b. Most commercially available NKCC1 antibodies,
including the one used in the present study, bind a C-terminal domain and target amino acids
encoded by exon 21 and, thus, would not detect the Nkcc1b splice variant encoded protein, as it
lacks exon 21 (Randall et al., 1997; Clayton et al., 1998; Vibat et al., 2001; Kaila et al., 2014;
Morita et al., 2014; Puskarjov et al., 2014a; Puskarjov et al., 2014b). This is an important point
when attempting to compare expression levels of NKCC1 genes and/or protein reported by
different researchers.
3.4.5

NKCC1 protein expression in SCN
Other researchers have addressed changes in NKCC1 protein across the day but none, to

our knowledge, tracked circadian changes in the free-running animal. For example, Belenky
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2010 used two antibodies to study NKCC1 expression in the SCN; one that putatively targets
both Nkcc1a and Nkcc1b encoded proteins and one that most likely targets only Nkcc1a encoded
protein, as we did in the present study (Belenky 2010). The antibody likely targeting protein
products of both Nkcc1a and Nkcc1b labeled somata and fibers while the Nkcc1a protein product
specific antibody seemed to stain mostly cell bodies, as we observed in our study. These same
researchers also described a slightly different expression pattern in the dorsoventral axis. When
using the putative Nkcc1a protein product specific antibody, animals sacrificed in the middle of
the day (ZT 5-7) showed a stronger signal in the dSCN than the vSCN, although the differences
were not quantified (Belenky et al., 2010). We also observed no differences between day and
night in hamsters entrained to a LD cycle. However, we found overall less robust staining in the
dSCN than the vSCN of animals housed in LD, in opposition to the findings described above
(Fig 3.5). When employing the antibody that most likely targets two different protein products of
the splice variants, Nkcc1a and Nkcc1b, the authors again suggest that no differences were found
between day and night expression (ZT5-7 and ZT 17, respectively) (Belenky et al., 2010). Again,
our findings agree with this lack of day/night differences in NKCC1 protein in animals from a
LD cycle (Fig 3.2). Importantly, the authors report that NKCC1 was found co-expressed with all
major SCN neuropeptides, including vasopressin, vasoactive intestinal polypeptide (VIP), and
gastrin releasing peptide (GRP) (Belenky et al., 2010). One of the only other reports of NKCC1
protein expression in the SCN used Western blot analysis. This report suggests that, in mice,
NKCC1 expression is higher in the dSCN in the night with no sub-regional differences in the day
(Choi et al., 2008). Again, neither of these studies measured NKCC1 protein expression in freerunning animals. The antibody used by Choi 2008 most likely targets Nkcc1a protein products,
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as in our study. The lack of consensus between these few studies could arise from differences in
the species studied or in the techniques used to measure NKCC1 protein.
3.4.6

Slc12a2 (Nkcc1) mRNA
Unlike our relative NKCC1 protein measurements, we did not observe time of

day/subjective day dependent differences in the expression of Slc12a2 (Nkcc1) in animals housed
in either LD 14:10 or DD conditions. A few different mechanisms could explain this observation.
For example, the number of functional chloride cotransporters is regulated by membrane
trafficking, activation and deactivation by phosphorylation and dephosphorylation, and
proteolytic cleavage (Delpire and Gagnon, 2008; Alessi et al., 2014; Kaila et al., 2014; Piala et
al., 2014). Thus, daily or circadian changes in any one of these post-translational modifications
could lead to changes in the rhythm of NKCC1 protein that is not evident at the transcript level.
Using the hamster whole brain transcriptome we found transcripts that most likely encode
different NKCC1 protein products but the functional significance of this is unknown (McCann et
al., 2017). Since we used a proprietary primer/probe set of unknown sequence, we are not able to
distinguish between these splice variants with our gene expression findings. It will be important
for future work to look at the functional significance of these Slc12a2 (Nkcc1) splice variants in
the SCN on expression and time-keeping mechanisms in the nuclei.
It is important to remember, however, that mRNA rhythms generally appear to be
uncoupled from protein rhythms in the SCN, and the presence of subunits does not necessarily
indicate the presence of functional GABAA receptor subtypes composed of those subunits (see
for a discussion)(Olsen and Sieghart, 2008; Challet et al., 2013).
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3.4.7

Time of day/circadian changes in NKCC1 protein
In addition to day length induced changes in NKCC1 and the excitatory:inhibitory

balance in the SCN, NKCC1 displayed changes in expression dependent on circadian time. This
suggests a role in circadian function for NKCC1 that may serve circadian clock functions such as
tuning phase shifts to light as well as non-photic shifts of the SCN. As mentioned, the NKCC1
inhibitor bumetanide injected into the SCN region decreases phase delays to light in the early
subjective night as well as non-photic like phase advances induced by the GABAAR agonist
muscimol in the middle of the subjective day (McNeill et al., 2018).
3.4.8

EGABA-time of day and region of SCN
Some in vitro studies report no time dependent differences in the effects of GABA

administration (Liou and Albers, 1990; Mason et al., 1991; Gribkoff et al., 1999; Gribkoff et
al., 2003). Other studies show GABA to be excitatory during the day in a substantial number of
SCN neurons (Wagner et al., 1997; Wagner et al., 2001). Still others report that GABA is
excitatory during certain parts of the night or subjective night (De Jeu and Pennartz, 2002; Choi
et al., 2008). For instance, using perforated patch recordings, De Jeu 2002 reported a depolarized
GABA current equilibrium potential (EGABA) (-59 mV) during the night while the day was more
hyperpolarized (-70 mV) (De Jeu and Pennartz, 2002). There also seems to be a discrepancy in
the literature as to the dorsal/ventral response to GABA. Some studies have found that GABA
has similar effects throughout the SCN (Shibata et al., 1983). Choi et al 2008, however, using
gramicidin perforated patch clamp recordings of 786 SCN neurons, shows GABA produces
excitation in a substantial proportion of neurons in both the dSCN and vSCN with the excitatory
effects of GABA most common in the dSCN at night (Choi et al., 2008). Other studies also
suggest differences in the excitatory to inhibitory balance that are dependent on time of day as
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well as sub-region of the SCN. One such study suggests that dSCN neurons have a depolarized
EGABA in the day (-30 mV) while vSCN neurons are more hyperpolarized (-60 mV) (Alamilla et
al., 2014). Interestingly, these important sub-regions change in the night with the dSCN
becoming hyperpolarized (-60 mV) and the vSCN depolarized (-30 mV). The depolarized EGABA
is attributable to NKCC1 as EGABA becomes more negative in both the vSCN and dSCN upon
bumetanide application (Alamilla et al., 2014). Further, differences in these findings may be
attributable to species and method of recording (Albers et al., 2017).
3.4.9

Intracellular chloride [Cl-i] - time of day and sub-region of SCN
As GABAARs can excite and inhibit neurons by the movement of chloride ions via its

ion-selective pore some researchers have effectively used measurements of intracellular chloride
concentration ([Cl-i]) in the SCN to describe these phenomena. For instance, chloride equilibrium
potentials are higher in the dSCN than in the vSCN, although no differences are observed in
chloride levels over time (DeWoskin et al., 2015). Another study uses chloride sensors to show
that the NKCC1 inhibitor bumetanide causes small changes in intracellular chloride
concentration [Cl-i] in the SCN. Surprisingly, bumetanide increases [Cl-i] in AVP+ neurons, and
decreases [Cl-i] in VIP+ neurons, as expected. KCC antagonism increases [Cl-i] in both AVP+
and VIP+ SCN neurons, as expected, upon inhibition of the chloride efflux protein. However,
bumetanide blocks the effects of a specific KCC2 antagonist on [Cl-i], suggesting NKCC1 is,
nevertheless, regulating chloride in SCN neurons, as shown in other brain regions (Klett and
Allen, 2017). To be sure, further work is necessary to determine the role for excitatory GABA
signaling in SCN mechanisms of phase resetting and synchronization of the network.
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3.4.10 GABAAR-evoked intracellular calcium concentration ([Ca2+])
Other labs have studied the cellular effects of GABA in the adult SCN by exploring how
GABA influences intracellular calcium concentrations ([Ca2+]) (Choi et al., 2008; Irwin and
Allen, 2009). In general, GABA-induced increases in [Ca2+] are associated with membrane
depolarization (excitation) while GABA-induced decreases in [Ca2+] are associated with
hyperpolarization (inhibition). Applying GABA to the hypothalamic slice preparation increases
[Ca2+] in some SCN neurons, decreases [Ca2+] in other SCN neurons, and has no effect on [Ca2+]
in still other SCN neurons (Irwin and Allen, 2009). Irwin and Allen (2009) show that more SCN
neurons increase [Ca2+] upon GABA application and fewer SCN neurons decrease [Ca2+] in the
night compared with the day. Furthermore, a higher proportion of neurons with increased [Ca2+]
upon GABA application lie in the dSCN than in the vSCN. The observed calcium responses
using RHT stimulation are similar to these GABA-evoked SCN responses. Similarly, the
GABAAR agonist muscimol increases [Ca2+] in some SCN neurons and reduces [Ca2+] in others
(Irwin and Allen, 2009).
3.4.11 Conclusion
The current experiments add to these findings suggesting that NKCC1 protein is
regulated by both light duration (i.e. photoperiod) and introduces the possibility that the SCN
exhibits a circadian rhythm in NKCC1 protein, though these fluctuations are different in DD and
LL. Importantly, the studies described above are some of the first to measure NKCC1 protein in
SCN neurons in both light dark and free-running conditions. These studies suggest a role for
NKCC1 in photic processing at the level of the SCN. The SCN offers a dense GABAergic
network with which to study GABA-induced excitation that is increasingly thought to play a role
in cell-to-cell signaling within the brain. Further, excitatory GABAAR responses are also known
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to be a part of the aberrant firing behavior associated with various pathological states, ranging
from autism and schizophrenia to excitotoxic conditions such as epilepsy and neuropathic pain
(MacKenzie et al., 2016; Merner et al., 2016; Yousuf and Kerr, 2016; Hadjikhani et al., 2018).
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4

CONCLUSIONS

Circadian rhythms are an evolutionary adaptation to environmental cycles resulting from
earth’s rotation about its axis and are found in most organisms. These rhythms help to “schedule”
biological functions at appropriate times of the light cycle (extrinsic advantages) and coordinate
internal physiological rhythms (intrinsic advantages) (Vaze and Sharma, 2013). For example,
activity levels, hormones, heartbeat, liver function, and neuronal activity all display circadian
rhythms.
4.1

Entrainment
Entrainment mechanisms in the suprachiasmatic nuclei (SCN) of the hypothalamus lead

to rhythmic physiologically and behaviorally relevant circadian rhythms. Entrainment is the
process by which organisms use light cues to synchronize biological rhythms to ever-changing
day lengths. Entrainment is an evolutionarily conserved mechanism through which an organism
maintains appropriate circadian rhythms relative to the sensory and metabolic environment in
which the animal exists. While it is becoming apparent that signals ranging from classic
peripheral hormones to feeding schedules can shift the central clock, the light dark cycle is
considered the strongest time-giver (zeitgeber). Light primarily entrains circadian rhythms
through retinal input to the SCN, a master pacemaker in the anterior hypothalamus. The neural
mechanisms regulating entrainment have been an area of intense study since the SCN was
identified as a master pacemaker over 40 years ago. The transcriptional/translational feedback
loop mechanisms (molecular clock), so well characterized in the SCN, are now recognized to
regulate rhythms and cellular responses throughout the body. However, the way in which these
self-sustained oscillations in single cells create a coherent output rhythm at the network level is
still an area of intense research. Obviously, these mechanisms are centered around
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neurotransmission; and with GABA so prevalent in the SCN, it is of great importance to further
our understanding of the role of GABA signaling within the pacemaker. Understanding these
mechanisms controlling entrainment is crucial due to the disorders and diseases that can arise
from impaired entrainment. In addition, the role of GABA signaling and, more specifically,
excitatory GABA signaling as regulated by chloride cotransporters, are appearing in the clinical
literature with increasing frequency.
4.2

Health risks associated with impaired entrainment
The impact of impaired entrainment is glaringly observed in human shift workers with

increased risks of metabolic disorders, cardiovascular disease, and cancer; but these risks affect
nearly 100% of the U.S. population through jetlag and social jetlag (Filipski et al., 2004; Davis
and Mirick, 2006; Tüchsen et al., 2006; Viswanathan et al., 2007; Niu et al., 2011). These
increased risks are especially critical to the over 15% of the population that performs shift work,
but also important to health care providers and taxpayers alike. As described above, the most
important functions of a biological clock are keeping time (endogenous rhythmicity) and
adjusting time to ever-changing environmental stimuli (entrainment) (Pittendrigh and Daan,
1976a; Golombek and Rosenstein, 2010). A host of physiological events are regulated. Thus, it
is no surprise that these increases in health risks occur (Kalsbeek et al., 2006). These disorders
make study of the cell-to-cell signaling pathways controlling light-signaled circadian clock
timing crucial for human health.
Beyond the increased health problems seen in shift workers, some suggest that over half
of the population suffers from social jetlag, or a discrepancy between the circadian and “social”
clocks (Wittmann et al., 2006). Social jetlag is linked to increased alcohol and cigarette use, low
mood, and increased risks of depression and weight gain (Wittmann et al., 2006; Roenneberg et
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al., 2012). Further, animal models of desynchrony demonstrate that chronic phase shifting leads
to a slew of pathologies (Golombek and Ralph, 1994; Penev et al., 1998; Filipski et al., 2004;
Davidson et al., 2008). Thus understanding the mechanisms controlling entrainment to light is of
utmost importance.
In addition, aberrant excitatory GABA signaling and, especially, chloride control of the
polarity of GABA responses, is increasingly recognized as a target for clinical research. For
example, neuropathological studies suggest that excitatory GABA signaling is involved in
neonatal seizures, temporal lobe epilepsy, and post-traumatic seizures (Kahle et al., 2008). The
common feature in these excitotoxic states is that the neurons display chloride gradients that
change GABA inhibition to excitation. This change is thought to involve changes in chloride
cotransporters, specifically an upregulation of the activity of NKCC1 (Kahle et al., 2008). Other
instances for a role of aberrant excitation by GABA have been found in neuropathic pain models.
For instance, a rat model of chronic constrictive injury, that induces trigeminal nucleus allodynia,
also includes an upregulation of Nkcc1 mRNA and protein and a down regulation of KCC2 on
the injured side of the nucleus (Wei et al., 2013). Another example of NKCC1 involvement in
pain pathways using induced referred mechanical hyperalgesia with in vivo intracolonic
instillation of capsaicin, found that this leads to phosphorylation (i.e., activation) and membrane
translocation of NKCC1 (Galan and Cervero, 2005). NKCC1 may be involved in producing
anxiety, and loop diuretics, such as bumetanide, may have anxiolytic properties. For instance,
bumetanide reduces conditioned anxiety in contextual fear conditioning and fear-potentiated
startle (Krystal et al., 2012). A heterozygous missense variant of the Slc12a2 gene that encodes
NKCC1 has been shown to predict schizophrenia (Merner et al., 2016). Bumetanide has also
been shown to restore GABAergic inhibition and decrease the motor effects of dopamine
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deprivation in a mouse model of Parkinson’s disease (Lozovaya et al., 2018). Inhibition of
NKCC1 normalizes EGABA in the PVN of spontaneously hypertensive rats and its increase in the
PVN may drive increases in sympathetic drive in animal models of hypertension (Ye et al.,
2012). Considering the range of disorders that involve NKCC1 in the whole organism, to say
research about how it contributes to both normal cell-to-cell signaling and how it can go haywire
in pathological states is important becomes an understatement.
4.3

Impact
Our data suggest a functional role for excitatory GABAAR signaling in the entrainment of

the pacemaker in the SCN. We showed that this excitatory type of GABAAR signaling, long
recognized in the SCN, plays a role in phase delays to light. Injection of bumetanide before a
phase delaying light pulse decreases the magnitude of a phase delay in the early subjective night.
Further, this type of GABA signaling is also likely involved in GABAAR non-photic advances in
the subjective day. Injection of bumetanide blocked these phase advances to muscimol (Chapter
2). We are the first, to our knowledge, to show a functional role within the SCN of excitatory
GABA signaling. We did not observe a rhythm in NKCC1 mRNA. However, NKCC1 protein
appears to maintain a circadian rhythm in both DD and LL conditions (Chapter 3). Furthermore,
we showed that LL conditions lead to increased NKCC1 expression throughout the Syrian
hamster SCN (Chapter 3). These findings suggest the possibility that the pacemaker is not only
involved in the changes in GABA excitation throughout the day, but also encodes the duration of
light at the level of the SCN. To our knowledge these are the first mRNA and protein profiles of
NKCC1 within the Syrian hamster SCN. As the Syrian hamster has long been a robust model in
circadian rhythms research, it is important to extend this model by including investigation of the
excitatory effects of GABAAR signaling.
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4.4

Study of GABAergic mechanisms
In addition to contributing to the growing understanding of the role of excitatory GABA

signaling in SCN mechanisms of entrainment, these experiments also contribute to our
understanding of CNS GABA signaling mechanisms, in general. GABA receptors, as alluded to
above, are the target of drugs for conditions ranging from insomnia to anxiety.
The SCN is well suited for in vivo study of the mechanisms of entrainment as well as the
mechanisms of GABA signaling in the brain as it has controllable inputs, such as light,
measurable behavioral and molecular outputs (e.g., phase shifts in behavior/gene expression),
and an abundance of GABA, GABA receptors, transporters, and other associated proteins, such
as NKCC1. In vitro studies have certainly taught us much about GABA mechanisms in the SCN
and in the CNS but in vivo approaches will have to be used to fully characterize these GABA
mechanisms as well as help translate these findings to the clinic. This is of utmost importance
considering the number of pathologies associated with this type of GABA signaling.
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